<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties manuscript?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">0060450</journal-id><journal-id journal-id-type="pubmed-jr-id">5506</journal-id><journal-id journal-id-type="nlm-ta">Lipids</journal-id><journal-id journal-id-type="iso-abbrev">Lipids</journal-id><journal-title-group><journal-title>Lipids</journal-title></journal-title-group><issn pub-type="ppub">0024-4201</issn><issn pub-type="epub">1558-9307</issn></journal-meta><article-meta><article-id pub-id-type="pmid">32519378</article-id><article-id pub-id-type="pmc">7725844</article-id><article-id pub-id-type="doi">10.1002/lipd.12263</article-id><article-id pub-id-type="manuscript">HHSPA1608100</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A Review of Efforts to Improve Lipid Stability during Sample Preparation and Standardization Efforts to Ensure Accuracy in the Reporting of Lipid Measurements</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ulmer</surname><given-names>Candice Z.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Koelmel</surname><given-names>Jeremy P.</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Jones</surname><given-names>Christina M.</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Garrett</surname><given-names>Timothy J.</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Aristizabal-Henao</surname><given-names>Juan J.</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2085-2396</contrib-id><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Vesper</surname><given-names>Hubert W.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bowden</surname><given-names>John A.</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3135-4015</contrib-id><xref ref-type="aff" rid="A5">5</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, MS F25, Atlanta, GA 30341, USA</aff><aff id="A2"><label>2</label>Department of Environmental Health Sciences, Yale School of Medicine, Yale University, 60 College Street, Room 510, New Haven, CT, 06520, USA</aff><aff id="A3"><label>3</label>Chemical Sciences Division, Organic Chemical Metrology Group, National Institute of Standards and Technology, 100 Bureau Drive, Gaithersburg, MD 20899, USA</aff><aff id="A4"><label>4</label>Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL 32610, USA</aff><aff id="A5"><label>5</label>Center for Environmental and Human Toxicology &#x00026; Department of Physiological Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL 32611, USA</aff><author-notes><corresp id="CR1"><label>&#x02709;</label>John A. Bowden <email>john.bowden@ufl.edu</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>30</day><month>6</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>09</day><month>6</month><year>2020</year></pub-date><pub-date pub-type="ppub"><month>1</month><year>2021</year></pub-date><pub-date pub-type="pmc-release"><day>14</day><month>1</month><year>2021</year></pub-date><volume>56</volume><issue>1</issue><fpage>3</fpage><lpage>16</lpage><!--elocation-id from pubmed: 10.1002/lipd.12263--><abstract id="ABS1"><p id="P1">Lipidomics is a rapidly growing field, fueled by developments in analytical instrumentation and bioinformatics. To date, most researchers and industries have employed their own lipidomics workflows without a consensus on best practices. Without a community-wide consensus on best practices for the prevention of lipid degradation and transformations through sample collection and analysis, it is difficult to assess the quality of lipidomics data and hence trust results. Clinical studies often rely on samples being stored for weeks or months until they are analyzed, but inappropriate sampling techniques, storage temperatures, and analytical protocols can result in the degradation of complex lipids and the generation of oxidized or hydrolyzed metabolite artifacts. While best practices for lipid stability are sample dependent, it is generally recommended that strategies during sample preparation capable of quenching enzymatic activity and preventing oxidation should be considered. In addition, after sample preparation, lipid extracts should be stored in organic solvents with antioxidants at &#x02212;20 &#x000b0;Cor lower in an airtight container without exposure to light or oxygen. This will reduce or eliminate sublimation, and chemically and physically induced molecular transformations such as oxidation, enzymatic transformation, and photon/heat-induced degradation. This review explores the available literature on lipid stability, with a particular focus on human health and/or clinical lipidomic applications. Specifically, this includes a description of known mechanisms of lipid degradation, strategies, and considerations for lipid storage, as well as current efforts for standardization and quality insurance of protocols.</p></abstract><kwd-group><kwd>Lipid standardization</kwd><kwd>Lipid storage and handling</kwd><kwd>Lipidomics</kwd><kwd>Metabolite stability</kwd><kwd>Sample preservation</kwd></kwd-group></article-meta></front><body><sec id="S1"><title>Overview of Lipid Stability</title><p id="P2">Lipids are ubiquitous and structurally complex molecules with diverse biological functions. The comprehensive analysis of lipids (lipidomics) has been recently useful in a plethora of plant, animal, and human studies. More notably, lipids in humans and animals have been shown over the past decade to be valuable for unmasking disease etiology (<italic>e.g.</italic>, serving as biomarkers for eating patterns (<xref rid="R19" ref-type="bibr">Canakci, 2007</xref>) as well as several diseases, including cardiovascular disease (<xref rid="R23" ref-type="bibr">De Caterina, 2011</xref>; <xref rid="R27" ref-type="bibr">Fung et al., 2001</xref>
<xref rid="R34" ref-type="bibr">Halliwell, 2000</xref>; <xref rid="R40" ref-type="bibr">Hinterwirth et al., 2014</xref>
<xref rid="R63" ref-type="bibr">Massaro et al., 2008</xref>; <xref rid="R80" ref-type="bibr">Ridker et al., 2005</xref>; <xref rid="R88" ref-type="bibr">Stegemann et al., 2014</xref>; <xref rid="R99" ref-type="bibr">Watson, 2006</xref>), chronic kidney disease (<xref rid="R53" ref-type="bibr">Kwan et al., 2007</xref>; <xref rid="R75" ref-type="bibr">Oberg et al., 2004</xref>), specific cancers (<xref rid="R3" ref-type="bibr">Aiello et al., 2005</xref>; <xref rid="R16" ref-type="bibr">Bozza and Viola, 2010</xref>
<xref rid="R25" ref-type="bibr">Fernandis and Wenk, 2009</xref>; <xref rid="R28" ref-type="bibr">Furberg et al., 2005</xref>
<xref rid="R35" ref-type="bibr">Han et al., 2005</xref>; <xref rid="R57" ref-type="bibr">Lonning et al., 2005</xref>; <xref rid="R91" ref-type="bibr">Sutphen et al., 2004</xref>; <xref rid="R100" ref-type="bibr">Xu et al., 2007</xref>; <xref rid="R104" ref-type="bibr">Zhou et al., 2012</xref>), and as general markers for oxidative damage (<xref rid="R22" ref-type="bibr">Dalle-Donne et al., 2006</xref>)). Despite the diversity in lipidomics applications, comprehensive and standardized studies that address how lipid stability is influenced by (1) sample collection conditions, (2) pre-analytical steps, and (3) matrix-specific sample preparation procedures are lacking in the literature (<xref rid="R1" ref-type="bibr">Abuja et al., 2015</xref>; <xref rid="R105" ref-type="bibr">Zivkovic et al., 2009</xref>). Lipid stability in this context is defined as the resistance of a lipid species to change or degrade during sample collection, preparation, handling, storage, and/or analysis (pre-analytical and analytical phase of the measurement process) through enzymatic or chemical processes (<italic>i.e.</italic>, in the presence of oxygen, water, light, and/or extreme temperatures). During these processes, lipids can undergo hydrolysis, oxidation, or interspecies conversion. Although lipid markers such as sphingadienine 1-phosphate (<xref rid="R46" ref-type="bibr">Kamlage et al., 2014</xref>; <xref rid="R56" ref-type="bibr">Liu et al., 2018</xref>), spingosine-1-phosphate (<xref rid="R46" ref-type="bibr">Kamlage et al., 2014</xref>), and lysophosphatidylcholine 18:2 (<xref rid="R4" ref-type="bibr">Anton et al., 2015</xref>) have been proposed as markers to assess sample quality and pre-analytical variation, these markers have not been assessed in larger cohort studies, in a panel with other lipid markers for lipid stability, or in other matrices apart from human serum and plasma. Therefore, lipid stability studies should be incorporated into the method development and validation process and matrix-dependent quality control measurements should be performed during lipidomics studies, as the degradation or interconversion of lipid species could potentially lead to misleading and/or irreproducible results.</p><sec id="S2"><title>Forms of Lipid Degradation</title><p id="P3">Lipid instability can be caused by a variety of factors such as chemical changes (<italic>e.g.</italic>, oxidation) biochemical/microbial enzymatic actions (<xref rid="R45" ref-type="bibr">Jones et al., 2007</xref>; <xref rid="R97" ref-type="bibr">Wang et al., 2015</xref>), or nonoxidative heating (<italic>e.g.</italic>, thermal decomposition) (<xref rid="R58" ref-type="bibr">Lorenz et al., 2011</xref>; <xref rid="R70" ref-type="bibr">Nawar, 1969</xref>). Chemical changes can trigger the release of hydrolyzed or oxidized lipid species. Hydrolysis is the enzymatic or nonenzymatic breakdown of lipids due to the presence of water.</p></sec><sec id="S3"><title>Lipid Instability by Oxidation</title><p id="P4">Oxidation is considered a major source of lipid degradation during sample collection, preparation, and storage. Oxidized lipid species are generated <italic>via</italic> several mechanisms (<italic>e.g.</italic>, autooxidation with free radicals, photooxidation, and lipoxygenase activity). The rate of oxidation is influenced by both the lipid substrate structure and extraction environment. Lipid structural components affecting the rate and types of oxidation products include the degree and location of the unsaturations on the fatty acyl chains (<xref rid="R102" ref-type="bibr">Yun and Surh, 2012</xref>) and lipid class (<xref rid="R86" ref-type="bibr">Shen and Wijesundera, 2009</xref>). During sample collection, the sample origin, the presence of water, (<xref rid="R102" ref-type="bibr">Yun and Surh, 2012</xref>), the temperature (<xref rid="R38" ref-type="bibr">Hess and O&#x02019;Hare, 1950</xref>; <xref rid="R55" ref-type="bibr">Liu et al., 2019</xref>), light, oxidants, and antioxidants can all affect oxidation products and the rate of oxidation. In <italic>in vivo</italic> studies, the rate of oxidation is influenced by the method of anesthesia (<xref rid="R68" ref-type="bibr">Mohamed et al., 2020</xref>; <xref rid="R103" ref-type="bibr">Zhang et al., 2013</xref>) or euthanasia (<xref rid="R37" ref-type="bibr">Hennebelle et al., 2019</xref>; <xref rid="R93" ref-type="bibr">Tr&#x000e9;panier et al., 2017</xref>). It is important to note that this difference could be tissue specific. For example, brain tissue may be affected differently than adipose tissue as suggested by <xref rid="R77" ref-type="bibr">Overmyer et al. (2015)</xref> in the analysis of metabolites in a mouse model.</p><p id="P5">As previously mentioned, oxidation rates are influenced by the quantity and location of double bonds in lipid species. Literature reports that double bonds located on fatty acyl chains in the <italic>sn</italic>-2 position of the glycerol backbone of triacylglycerols are less susceptible to oxidation (<xref rid="R86" ref-type="bibr">Shen and Wijesundera, 2009</xref>). It is postulated that the location of glycerophospholipids in membranes, the increased proportion of polyunsaturated fatty acids (PUFA) for membrane fluidity, and the relative proximity to oxidative enzymes make glycerophospholipids more susceptible to oxidation compared to triacylglycerols.(<xref rid="R2" ref-type="bibr">Ademowo et al., 2017</xref>) In addition, oxygen and other nonpolar oxidants can concentrate in the nonpolar region of the membrane where highly oxidizable polyunsaturated fatty acids reside. PUFA-containing cholesteryl esters have also been observed to be susceptible to oxidation when exposed to ambient air (<xref rid="R11" ref-type="bibr">Bowden et al., 2011</xref>), and several PUFA-derived bioactive lipids such as prostaglandin D2, peptidoleukotrienes, and 5 (6)epoxyeicosatrienoic acid are highly unstable and can undergo spontaneous nonenzymatic conversion into other metabolites (<xref rid="R20" ref-type="bibr">Carmella et al., 2019</xref>; <xref rid="R24" ref-type="bibr">Dorow et al., 2016</xref>; <xref rid="R61" ref-type="bibr">Maddipati and Zhou, 2011</xref>; <xref rid="R62" ref-type="bibr">Maskrey and O&#x02019;Donnell, 2008</xref>). Conversely, many lipids that do not contain PUFA such as steroid hormones and those with saturated fatty acyl moieties appear to be less labile (<xref rid="R42" ref-type="bibr">Holl et al., 2008</xref>; <xref rid="R44" ref-type="bibr">Jane Ellis et al., 2003</xref>). Hydrogens on methylene groups adjacent to a double bond (allylic hydrogens) or two double bonds (bis-allylic hydrogens) have much lower C&#x02013;H bond energies than those in unsaturated lipids, and hence can readily be abstracted by free radicals. Bis-allylic hydrogens have the weakest C&#x02013;H bond and are hundreds of times more reactive with free radicals than allylic hydrogens (<xref rid="R67" ref-type="bibr">Min and Ahn, 2005</xref>). Therefore, an increase in the degrees of unsaturation results in a higher susceptibility to oxidation, making lipid species of marine origin more unstable due to the high number of PUFA.</p><p id="P6">Oxidized lipids can abstract hydrogens from adjacent bis-allylic hydrogens, inducing a chain oxidation reaction as lipids are often found in aggregates such as micelles and bilayers. This mechanism is termed lipid peroxidation or autoxidation (<xref rid="F1" ref-type="fig">Fig. 1</xref>) and has been discussed in detail in a previous review (<xref rid="R66" ref-type="bibr">Metherel and Stark, 2016</xref>). Autooxidation is the oxidation of lipid species <italic>via</italic> a three-step free radical mechanism (initiation, propagation, and termination) due to the presence of oxygen and/or metals. The initial products of autooxidation (peroxides) can be further transformed into secondary oxidation products such as long-chained oxidized species (<italic>e.g.</italic>, ketone, hydroxy, hydroperoxyl, and epoxy containing species) and short-chained oxidized species (<italic>e.g.</italic>, species ending in a carboxylic acid or aldehyde). Photooxidation type I involves the abstraction of a hydrogen or electron from a triple state sensitizer, which yields a free radical (<xref rid="R85" ref-type="bibr">Shahidi and Zhong, 2010</xref>). Photooxidation type II involves the excitation of oxygen to a more reactive, excited singlet state <italic>via</italic> an energy transfer from a triplet sensitizer. Lastly, lipoxygenase involves the enzymatic conversion of polyunsaturated fatty acids to conjugated dienes, which then react with oxygen to form peroxyl radicals and hydroperoxides.</p></sec><sec id="S4"><title>Lipid Instability by Enzymatic Activity</title><p id="P7">Based on the matrix, lipids can become subject to enzymatic degradation prior to analysis by enzymes such as lecithin cholesterol acyltransferase and phospholipases. In addition, dehydration and hydrolysis reactions under enzymatic conditions can be catalyzed by lipase activity. Common enzymatic reactions involving glycerophospholipids and glycerolipids during sample handling have been discussed elsewhere. Phospholipase A<sub>1</sub> (PLA<sub>1</sub>) and PLA<sub>2</sub> are responsible for the hydrolysis of glycerophospholipids in the <italic>sn</italic>-1 and <italic>sn</italic>-2 position of the glycerol backbone, respectively (<xref rid="F2" ref-type="fig">Fig. 2</xref>). Failure to inhibit the activity of PLA<sub>1</sub> and PLA<sub>2</sub> during sample preparation results in elevated levels of lysoglycerophospholipids and free fatty acids. In addition, phospholipase D is responsible for the cleavage of glycerophospholipids into phosphatidic acids, which are converted to diacylglycerols <italic>via</italic> phosphatidic acid phosphohydrolase (<xref rid="F2" ref-type="fig">Fig. 2</xref>). Alcohols such as methanol and ethanol can be used during extraction, and these alcohols in the presence of phospholipase D can act as acceptors in transphosphatidylation, leading to the ethylation of methylated lipid species (<xref rid="R83" ref-type="bibr">Roughan et al., 1978</xref>) (<xref rid="F2" ref-type="fig">Fig. 2</xref>). The generation of transphosphatidylation products such as phosphatidylethanol (PEt) and phosphatidylmethanol (PMe) can occur at low concentrations (<italic>i.e.</italic>, the generation of PEt species during alcohol consumption (<xref rid="R39" ref-type="bibr">Hill-Kapturczak et al., 2018</xref>)) as well as in the case of extraction where the solvent extraction mainly consists of methanol (<xref rid="R51" ref-type="bibr">Koelmel et al., 2018</xref>). Therefore, even trace levels of solvent contamination may generate unwanted lipid byproducts. Literature has shown lower temperatures to play a substantial role in the inactivation of enzymes, whereas samples undergoing sample preparation at ambient temperatures are subject to enzymatic activity (<xref rid="R41" ref-type="bibr">Hjm Jansen, 2014</xref>; <xref rid="R60" ref-type="bibr">Lu et al., 2017</xref>; <xref rid="R101" ref-type="bibr">Yang et al., 2013</xref>). Heat treatment, further discussed below, can also reduce enzymatic degradation.</p><p id="P8">The use of structurally similar internal standards that are spiked prior to lipid extraction can help to compensate for the loss of certain lipid classes during sample preparation as well as variability due to the lipid extraction. Limitations of this approach include the lack of reliable internal standards covering all lipids of interest, differences in degradation within a lipid class (<italic>e.g.</italic>, based on unsaturation location), and the high cost of standards.(<xref rid="R50" ref-type="bibr">Koelmel et al., 2019</xref>) In addition, reliable internal standards for certain lipid groups such as oxidized lipid species are lacking commercially. Therefore, lipid degradation should be limited to the greatest extent possible. One such way to reduce lipid degradation is through quenching enzymatic activity, which potentially halts the metabolism of lipids in an effort to maintain the original concentration of cellular lipid species. Recommendations in literature support the rapid use of cold organic solvents, such as methanol, to quench enzymatic activity early during sample preparation and to prevent the enzymatic degradation of lipid species (<xref rid="R48" ref-type="bibr">Kirkwood et al., 2013</xref>; <xref rid="R60" ref-type="bibr">Lu et al., 2017</xref>). Quenching can also be accomplished with a rapid change in temperature to either low (below &#x02212;40 &#x000b0;C) or high temperature (above 80 &#x000b0;C) conditions, as well as by implementing extreme pH conditions. It should be noted that the process implemented for quenching is sample-dependent and careful consideration must be placed on the process to avoid the possible chemical degradation of certain lipid species (<xref rid="R31" ref-type="bibr">Gil et al., 2019</xref>) or the production of artifacts.</p><p id="P9">Various reports have highlighted the importance of utilizing plasma instead of serum in lipidomic studies through the collection of blood in the presence of EDTA, heparin, or other anticoagulants. Plasma profiles are believed to provide the most reliable representation of profiles <italic>in vivo,</italic> as significant differences in lipidomic profiles between plasma and serum have been shown (<xref rid="R6" ref-type="bibr">Aoki et al., 2002</xref>; <xref rid="R5" ref-type="bibr">Aoki et al., 2008</xref>; <xref rid="R7" ref-type="bibr">Aristizabal-Henao et al., 2019</xref>; <xref rid="R43" ref-type="bibr">Ishikawa et al., 2014</xref>). There are multiple explanations for this observation. Plasma is typically processed faster than serum, which is obtained from coagulated blood, as no clotting time is needed. Parameters that affect the clotting process in serum include the clotting time, temperature, and the type of blood collection tube (<italic>e.g.</italic>, with clot activators containing glass or siliceous materials, and thrombin or with gel separation) (<xref rid="R8" ref-type="bibr">Arzu et al., 2019</xref>; <xref rid="R15" ref-type="bibr">Bowen and Remaley, 2014</xref>; <xref rid="R17" ref-type="bibr">Burla et al., 2018</xref>; <xref rid="R72" ref-type="bibr">Ng and Yeo, 2013</xref>). The effect of these parameters on clinical testing has been explained in detail elsewhere (<xref rid="R15" ref-type="bibr">Bowen and Remaley, 2014</xref>). Certain changes in lipid metabolism may not be detected in serum because the blood clotting process elevates the levels of particular lipids such as lysophosphatidylcholines and diacylglycerols (<xref rid="R43" ref-type="bibr">Ishikawa et al., 2014</xref>). It has been proposed that during the clotting process, lipids and lip-idaltering enzymes are released, which can result in the generation or degradation of various lipid species such as lysoglycerophospholipids, sphingosine-1-phosphates (S1P), prostaglandins, and oxylipins (<xref rid="R17" ref-type="bibr">Burla et al., 2018</xref>; <xref rid="R43" ref-type="bibr">Ishikawa et al., 2014</xref>). It is generally recommended for lipidomic studies to obtain plasma from venous blood as opposed to capillary blood collected from a finger prick, which is often used in point-of-care testing and screening, to avoid hemolysis as well as contamination from cosmetics, skin tissue fluid, and antiseptics (<xref rid="R17" ref-type="bibr">Burla et al., 2018</xref>). More specifically, cosmetics and skin tissues contain lipid species that could skew the lipid profile of interest, could cause interferences, and could potentially result in ion suppression. Plasma preparation from whole blood collected in tubes containing an anticoagulant is preferred, as anticlotting agents such as EDTA can capture heavy metals (<xref rid="R26" ref-type="bibr">Ferrero, 2016</xref>; <xref rid="R47" ref-type="bibr">Kensova et al., 2014</xref>), which are pro-oxidants. However, it has been reported that the type of anticoagulant (<italic>e.g.</italic>, EDTA, lithium heparin, and citrate) used can impact lipid extraction, create interferences, or result in the degradation of certain lipid classes (<xref rid="R17" ref-type="bibr">Burla et al., 2018</xref>). There are currently no recommendations on which anticoagulant should be used for lipidomics studies, as there is limited research available on the effects of specific anticoagulants on the lipidome. A primary finding has suggested that the calcium-chelating effects of EDTA and citrate, but not heparin, may inhibit the calcium-dependent <italic>ex vivo</italic> formation or degradation of certain lipid classes (<xref rid="R32" ref-type="bibr">Gonzalez-Covarrubias et al., 2013</xref>). Therefore, the same anticoagulant should be utilized for all samples within a study and among studies that will be compared since each anticoagulant can impact the lipidome differently.</p><sec id="S8"><title>Lipid Instability by Nonoxidative Heating</title><p id="P10">While enzymatic activity can be controlled or decreased, for example, by quenching using organic solvents following sample collection and/or handling the sample at low temperatures, nonenzymatic activity regulation such as chemical degradation due to pH and temperature should be given an equal amount of attention (<xref rid="R30" ref-type="bibr">Gil et al., 2015</xref>; <xref rid="R33" ref-type="bibr">Haid et al., 2018</xref>; <xref rid="R87" ref-type="bibr">Sohaib et al., 2015</xref>). Nonenzymatic, nonoxidative chemical degradation ultimately affects the quality of the lipidomic datasets and the ability to infer biological responses to physiological changes because it could lead to the complete disappearance of certain lipid species or their conversion into another chemical species. For example, sample preparation procedures traditionally used for lipid analysis often involve acid/base hydrolysis under high temperatures for an extended period, which can lead to the dimerization and polymerization of unsaturated fatty acids (<xref rid="R70" ref-type="bibr">Nawar, 1969</xref>, <xref rid="R71" ref-type="bibr">1984</xref>). In addition, very high temperatures can result in the nonoxidative decomposition of saturated fatty acids (<xref rid="R71" ref-type="bibr">Nawar, 1984</xref>). The effects of nonoxidative thermal degradation have been explained in detail elsewhere (<xref rid="R70" ref-type="bibr">Nawar, 1969</xref>).</p><p id="P11">Unfortunately, nonenzymatic chemical degradation and other types of degradation, which occur prior to extraction of the sample, cannot be corrected for <italic>via</italic> the use of spiked internal standards and thus, degradation and conversion must be prevented or accounted for prior to extraction (<xref rid="R30" ref-type="bibr">Gil et al., 2015</xref>). For cell culture studies, an isotopically labeled growth medium incorporated within cells (<italic>i.e.</italic>, fully isotopically labeled reference material similar to that offered by the isotopic ratio outlier analysis (IROA) quantitation kit (<xref rid="R78" ref-type="bibr">Qiu et al., 2016</xref>; <xref rid="R90" ref-type="bibr">Stupp et al., 2013</xref>)), is useful in accounting for effects of degradation as it would account for the same environmental conditions across time as the endogenous lipid species. In addition to the IROA approach, lipidome isotope labeling of yeast (LILY) has been proposed as an <italic>in vivo</italic>
<sup>13</sup>C labeling technique to produce isotopically labeled eukaryotic lipid standards in yeast (<xref rid="R79" ref-type="bibr">Rampler et al., 2018</xref>). While these techniques have significant advantages, limitations include that this technique can be expensive, the incorporation of labels into lipids is often incomplete, and not all untargeted lipidomics studies need stable isotopes to identify biomarkers, which makes their use less common in metabolomics.</p></sec></sec><sec id="S9"><title>Strategies for Improving Lipid Stability</title><p id="P12">As previously mentioned, lipid stability is influenced by the sample type, sample collection workflow, sample preparation procedure, and sample storage conditions. <xref rid="T1" ref-type="table">Table 1</xref> contains suggested recommendations that can be employed to address these lipid stability concerns. The National Institute of Standards and Technology (NIST) conducted a lipidomics survey that included 125 respondents from laboratories across 5 continents and 32 countries (<xref rid="R14" ref-type="bibr">Bowden et al., 2018</xref>). The survey questions targeted information on employed lipidomic methodologies, quantitation practices, and protocols related to quality controls. There was only one question that probed responses on lipid stability, &#x0201c;What strategies (if any) does your laboratory employ for enhancing/monitoring lipid stability (select those that apply)?&#x0201d; Respondents suggested the following approaches to address lipid stability: the use of internal/recovery standards (n = 96), sample preparation performed on ice (n = 76), flash freezing (n = 62), antioxidant addition (n = 54), derivatization (n = 27), the use of inhibitors (n = 14), and the use of heat treatment (n = 6). Based on the responses, it appeared that most laboratories incorporated one or more of the techniques mentioned above during a single sample preparation workflow to avoid lipid degradation. However, this same survey highlighted that only 25 out of 122 respondents had standard operating procedures (SOP) for monitoring lipid stability. It is important to include and follow optimized steps to ensure lipid stability in a laboratory SOP, while limiting the implementation of unnecessary and/or impractical preventative strategies if the lipid(s) that are being interrogated do not require it.</p></sec><sec id="S10"><title>Flash Freezing</title><p id="P13">Flash freezing in liquid nitrogen at &#x02212;196 &#x000b0;C, one of the most commonly employed techniques for sample preservation, drastically reduces physical, chemical, and enzymatic degradation/transformation. Ideally, sample handling at a low temperature (&#x02212;40 &#x000b0;C) would be maintained throughout all steps of sample storage, sample preparation, and data acquisition to prevent degradation. However, lipid solubility could be impacted even when working with organic solvents such as chloroform, causing some lipids to precipitate out of solution. Additionally, temperature regulation at low temperature that ensures quenching of enzymatic activity throughout the entire workflow is impractical for most laboratories employing common strategies or available technologies. Companies that provided cryogenic sample preparation and sample introduction are less prominent, owing to the lack of demand from the community, the high price of implementation, and the lack of awareness in the community about the impact of sample preparation on results. Therefore, additives or pre-analytical techniques that enhance lipid stability are useful as an additional step to cryogenic sample storage and handling.</p></sec><sec id="S11"><title>Additives</title><p id="P14">Additives can be applied to reduce both physical degradation (<italic>e.g.</italic>, oxidation) and enzymatic degradation. As an example of reducing enzymatic degradation, Wang et al. proposed the use of 5 mM phenylmethanesulfonyl fluoride (PMSF) as a sample pretreatment, prior to sample extraction, to increase the stability of glycerophospholipids, glycerolipids, and sphingolipids (<xref rid="R97" ref-type="bibr">Wang et al., 2015</xref>). The authors demonstrated higher levels of phosphatidylcholine and phosphatidylethanolamine compared to the respective lysoglycerophospholipids, thus suggesting the inhibition of phospholipase (PLA) activity. In addition, elevated levels of triacylglycerols compared to the downstream products of diacylglycerols and free fatty acids were reported, suggesting reduced hydrolysis. Reduced degradation of lipids in the presence of PMSF is likely due to the deactivation of serine hydrolase activity in proteins and enzymes <italic>via</italic> covalent binding to these active sites. Serine hydrolase is incorporated into numerous lipases, including phospholipases, owing to its nucleophilic serine residue, which can hydrolyze lipids and other molecules. Therefore, the deactivation of serine leads to a reduction in lipid enzyme degradation <italic>via</italic> hydrolysis.</p></sec><sec id="S12"><title>Antioxidants</title><p id="P15">In addition to additives for the reduction of enzymatic activity, various antioxidants have also been reported as additive options used to decrease the incidence of oxidation during sample preparation and storage, depending on the application. Additionally, a recent primary study showed dietary supplementation with antioxidants in birds to improve the stability of lipids <italic>ex vivo</italic> (<xref rid="R87" ref-type="bibr">Sohaib et al., 2015</xref>). Antioxidants reduce or prevent oxidation <italic>via</italic> various mechanisms as quenchers of oxidation products and/or reactive singlet oxygen, scavengers of free radicals, metal&#x02013;ion chelators, and enzyme inhibitors (<xref rid="R10" ref-type="bibr">Blanco and Blanco, 2017</xref>; <xref rid="R59" ref-type="bibr">L&#x000fc; et al., 2010</xref>; <xref rid="R74" ref-type="bibr">Nimse and Pal, 2015</xref>). Antioxidants are generally introduced during sample preparation or added for long-term storage due to their low cost and high effectiveness. Examples of antioxidants reported in literature include butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), ascorbic acid, carotenoids, transferrin, deferoxamine, methyl silicone, phosphoric acid, propyl gallate (PG), tocopherols, quercetin, and tertiary butylhydroquinone (TBHQ).</p></sec><sec id="S13"><title>Heat Treatment</title><p id="P16">While additives are useful chemical methods for increasing lipid stability in plasma and urine, it is challenging to implement additives in tissue samples prior to pulverization, homogenization, and extraction. Heat treatment, a technique employed since the 1940s, has been shown to promote the stability of certain lipid species including phospholipids, neutral lipids (<italic>e.g.</italic>, triacylglycerols), and sphingolipids during sample preparation <italic>via</italic> inhibition of lipases, including phospholipase A, C, and D activity (<xref rid="R51" ref-type="bibr">Koelmel et al., 2018</xref>; <xref rid="R81" ref-type="bibr">Rose et al., 2008</xref>). Heat treatment has the advantage of being applied at the time of collection, such as in environmental field studies, where access to liquid nitrogen or securing options for flash freezing is difficult. Heat treatment can be directly applied to tissues, whole animals, or serum/plasma in a vacuum-sealed chamber without solvent. In addition, the solvent can be rapidly heated during extraction (<xref rid="R51" ref-type="bibr">Koelmel et al., 2018</xref>). Generally, if the technology is available, the prior is desirable in that it reduces enzymatic activity earlier on during sample preparation and hence any associated enzymatic transformation of lipids. It is important to note that nonenzymatic physical and chemical transformation/degradation of lipids are not accounted for by heat treatment. While heat treatment reduces enzymatic activity, physical degradation, for example <italic>via</italic> oxidation, can still occur even though the application of heat treatment under vacuum may not increase the oxidation of lipids (<xref rid="R81" ref-type="bibr">Rose et al., 2008</xref>). It is often enzymatic degradation that is most significant at the small intervals between thawing and extraction, especially in tissues, whole blood, or cell cultures where the release of calcium upon cell pulverization activates enzymes to begin to degrade and transform lipids. Therefore, heat treatment is an effective approach for drastically increasing lipid stability during extraction and short-term sample handling.</p></sec><sec id="S14"><title>Considerations for Lipid Storage</title><p id="P17">The abovementioned NIST lipidomics survey questioned 122 laboratories on temperatures used to store lipid extracts, resulting in 174 responses. Most respondents indicated that lipid extracts were stored in either a &#x02212;80 &#x000b0;C freezer (n = 96) or &#x02212;20 &#x000b0;C freezer (n = 55). However, a few laboratories mentioned the storage of lipids at room temperature (n = 2) or in a refrigerator (n = 14).</p><p id="P18">The stability and interconversion of lipids can be heavily impacted by external factors such as storage and freeze&#x02013;thaw cycles. The type of sample that is to be stored will certainly influence the storage procedure employed to ensure lipid stability (<xref rid="R18" ref-type="bibr">Burtis et al., 2013</xref>). It is still unknown how storage and freeze&#x02013;thaw cycles affect the entire lipidome as there appears to be sample-dependent effects (<xref rid="R89" ref-type="bibr">Stevens et al., 2019</xref>; <xref rid="R105" ref-type="bibr">Zivkovic et al., 2009</xref>). While the general idea for sample preservation is to freeze samples quickly and store at a low temperature, this principle does not consider the exact storage temperature or the physical state in which the sample should be stored (<italic>e.g.</italic>, in solution, dried under nitrogen, with preservatives/additives, <italic>etc.</italic>). While literature has shown the rate of autoxidation to decrease at lower temperatures and hence cryopreservation or freezing can be used to store lipids (<xref rid="R38" ref-type="bibr">Hess and O&#x02019;Hare, 1950</xref>; <xref rid="R55" ref-type="bibr">Liu et al., 2019</xref>; <xref rid="R96" ref-type="bibr">Velasco and Dobarganes, 2002</xref>), an exception can occur when autoxidation is induced during freezing. For example, in the case of red blood cell-containing samples, lysis can occur due to water expansion, and the resulting release of iron can drive autoxidation (<xref rid="R64" ref-type="bibr">Metherel et al., 2013</xref>; <xref rid="R65" ref-type="bibr">Metherel and Stark, 2015</xref>).</p><p id="P19">For long-term storage after sample preparation, lipid extracts should generally be stored in an airtight container at &#x02212;20 &#x000b0;C or lower in organic solvent to avoid sublimation, an area free of light and oxygen, and in the presence of antioxidants for liquids. Lipids stored as a lyophilized material are more prone to hydrolysis and/or oxidation due to their hygroscopic behavior. There is also a lack of clear guidance between the recommendations for lipid extract storage at &#x02212;20 &#x000b0;C or temperatures lower than &#x02212;20 &#x000b0;C. It is suggested that organic solutions of phospholipids should not be stored at temperatures lower than &#x02212;20 &#x000b0;C unless they are stored in glass. It is also recommended that lipid classes, such as glycerophospholipids, not be stored in aqueous solutions for extended periods of time due to the potential for hydrolysis. Plastic and/or polymer-based containers should not be used to store organic solutions of lipid extracts as these organic solvents can leach the plastics. The number of freeze&#x02013;thaw cycles should remain limited as literature has shown up to a 37% variability in HDL- and LDL-cholesterol from one freeze&#x02013;thaw cycle. An environment rich in water, oxygen, and/or light may cause the chemical transformation of certain lipid species despite storage at a low temperature (&#x02212;20 &#x000b0;C or lower) (<xref rid="R41" ref-type="bibr">Hjm Jansen, 2014</xref>).</p><p id="P20">Literature has shown that the temperature, duration of storage, and presence of enzymatic activity all affect lipid stability differently depending on the lipid class and sample type (<xref rid="R41" ref-type="bibr">Hjm Jansen, 2014</xref>; <xref rid="R82" ref-type="bibr">Roszkowska et al., 2018</xref>; <xref rid="R105" ref-type="bibr">Zivkovic et al., 2009</xref>). Jansen et al. demonstrated that while HDL- and LDL-cholesterol, triacylglycerols, and apolipoprotein-A1 and B were fairly stable at &#x02212;20 &#x000b0;C, fatty acids showed levels of degradation as high as 80% (<xref rid="R41" ref-type="bibr">Hjm Jansen, 2014</xref>). The authors also reported no significant differences between lipid storage at &#x02212;70 and &#x02212;196 &#x000b0;C over the course of 12 months, suggesting that a temperature lower than &#x02212;20 &#x000b0;C may be more ideal. This observation was reflected in a fatty acid stability study (<xref rid="R64" ref-type="bibr">Metherel et al., 2013</xref>), where the concentrations of eicosapentaenoic acid and docosahexaenoic acid (two omega-3 PUFA) in dried-blood spots decreased more rapidly when stored at &#x02212;20 &#x000b0;C as compared with room temperature, 4, and &#x02212;80 &#x000b0;C. In addition, studies on the lipid profiles in human milk showed that enzymatic activity was more reduced at &#x02212;70 &#x000b0;C or &#x02212;80 &#x000b0;C compared to &#x02212;20 &#x000b0;C (<xref rid="R29" ref-type="bibr">Fusch et al., 2015</xref>; <xref rid="R54" ref-type="bibr">Lev et al., 2014</xref>). Laboratories should consider an in-house freeze&#x02013;thaw stability and short-term/long-term storage stability evaluation for each sample-type.</p><p id="P21">Extreme care should be taken for the lipidomic analysis of stored cell cultures. While cells can be stored at a much lower temperature in liquid nitrogen to reduce lipid instability, cells would then have to be introduced to a cryopreservant solution containing DMSO, which may cause a high background in mass spectrometry-based studies.</p><p id="P22">While written for a wide range of metabolites, the Centers for Disease Control and Prevention (CDC) has provided a resource, Improving the Collection and Management of Human Samples Used for Measuring Environmental Chemicals and Nutrition Indicators, that describes the best practices for the collection and storage (<italic>e.g.</italic>, whole blood, blood cells, serum, saliva, and urine) to ensure analyte integrity (<xref rid="R21" ref-type="bibr">Centers for Disease Control and Prevention, 2018</xref>). The considerations presented can certainly be transferable to the design of lipidomics studies.</p></sec><sec id="S15"><title>Standardization Efforts for Accuracy in Lipid Measurements</title><p id="P23">Quality assurance (QA) and quality control (QC) measures are necessary to ensure the harmonization of lipid measurements (<xref rid="R17" ref-type="bibr">Burla et al., 2018</xref>). Efforts are ongoing to establish external lipid QA and standardization programs. The CDC established the Lipids Standardization Program (LSP) to ensure the analytical accuracy and precision of select lipid measurements reported in research and clinical laboratories (<xref rid="R98" ref-type="bibr">Warnick et al., 2008</xref>). Blinded high-quality pooled sera samples with target values determined by generally recognized reference methods for certain lipids such as total cholesterol (TC), triacylglycerols (TAG), high-density lipoprotein cholesterol (HDL-C), apolipoprotein A-I (apo A-I), and apolipoprotein B (apo B) are provided to participants of the LSP program over a 3-month period. A statistical report that provides information about measurement consistency and whether established analytical performance criteria were met is provided to the LSP participants. Using this approach, laboratories can test the accuracy of their measurements from an <italic>in-house</italic> established protocol to ensure that these lipid measurements over time are not affected by pre-analytical factors such as storage and stability. CDC provides similar programs for other analytes such as steroid hormones and vitamin D.</p><p id="P24">In addition, a clinical or research laboratory with a lab-developed test can seek a 6-month certification by the CDC for TC through a collaboration with a Cholesterol Reference Method Laboratory Network (CRMLN) member laboratory (<xref rid="R69" ref-type="bibr">Myers et al., 2000</xref>). Briefly, the laboratories analyze six high-quality serum samples over a pre-determined concentration range to ensure that specific analytical criteria are met (<italic>i.e.</italic>, &#x000b1;3.0% maximum allowable bias to the reference method and a &#x02264; 3.0% CV maximum allowable imprecision) and traceability is established to the National Reference System for Cholesterol (NRS/CHOL). After meeting the certification criteria, the clinical laboratory or research laboratory is issued a 6-month valid Certificate of Traceability, which states that the analytical system (<italic>e.g.</italic>, instrument model, reagent, lot, calibrator lot, and matrix) successfully demonstrated traceability to the NRS/CHOL under the tested conditions. In all of these CDC programs, procedures are used that ensure the stability of the specific lipids during processing, storage, and transport.</p><p id="P25">NIST, in collaboration with the National Institutes of Health (NIH) Office of Dietary Supplements (ODS), has been actively involved in harmonizing fatty acid measurements in biological samples, particularly blood plasma and serum. NIST and NIH ODS established Fatty Acids in Human Serum and Plasma Quality Assurance Program (FAQAP) that administered interlaboratory comparison exercises for the measurement of 24 fatty acids in selected freeze-dried and frozen plasma and serum matrices. For these studies, participants utilized their typical analytical workflows to analyze samples; the main goal was to assess laboratory performance and gain a better understanding of fatty acid measurement variability across laboratories. Moreover, NIST helped participants troubleshoot their analytical methods when requested. For the first exercise (<xref rid="R84" ref-type="bibr">Schantz et al., 2013</xref>), a collaboration with the CDC conducted in 2012, participants measured fatty acid concentrations in NIST SRM 2378 &#x02013; Fatty Acids in Human Serum, which is composed of serum from (1)donors who had not consumed fish or flaxseed oil supplements for 1 month prior to sample collection, (2) donors who consumed flaxseed oil supplements for 1 month minimum before sample collection, and (3) donors who consumed fish oil supplements for 1 month minimum before sample collection. This first effort demonstrated the urgent need for quality control materials that can be used to increase lipid measurement comparability across laboratories. Although FAQAP formally ended in 2017, NIST and NIH ODS has since formed the Health Assessment Measurements Quality Assurance Program (HAMQAP) (<xref rid="R9" ref-type="bibr">Barber et al., 2018</xref>), which continues to serve the fatty acid measurement community. HAMQAP administers interlaboratory comparison exercises where participants measure a host of analytes, including fatty acids, in samples issued by NIST that represent both human intake (<italic>e.g.</italic>, food, dietary supplements) and output (<italic>e.g.</italic>, plasma, serum, urine) so that laboratories can assess their <italic>in-house</italic> measurements. Participation can be utilized to fulfill requirements established by accreditation bodies or to show compliance with the Food and Drug Administration (FDA) Current Good Manufacturing Practices (CGMP).</p><p id="P26">While the abovementioned approaches by the CDC and NIST/NIH ODS ensure accuracy for targeted lipid applications, NIST established a method validation tool for robust untargeted lipidomics platforms using LipidQC (<xref rid="R95" ref-type="bibr">Ulmer et al., 2017</xref>). Users can visually compare experimental results from the NIST Standard Reference Material (SRM) 1950, &#x0201c;Metabolites in Frozen Human Plasma&#x0201d;, against benchmark consensus mean concentrations derived from the NIST Lipidomics Interlaboratory Comparison Exercise (<xref rid="R13" ref-type="bibr">Bowden et al., 2017a</xref>; <xref rid="R12" ref-type="bibr">Bowden et al., 2017b</xref>), which was published in 2017. It is important to note that the consensus values reported are based on measurements across laboratories that as a whole demonstrated much variation due to the different methodologies employed. Therefore, consensus values may not be synonymous with a high level of measurement accuracy and instead should be used as a point of reference. Furthermore, other community-wide efforts such as the Lipidomics Standards Initiative (<ext-link ext-link-type="uri" xlink:href="https://lipidomics-standards-initiative.org/">https://lipidomics-standards-initiative.org/</ext-link> ), Lipid MAPS (<ext-link ext-link-type="uri" xlink:href="http://lipidmaps.org/">http://lipidmaps.org/</ext-link>), and the newly formed International Lipidomics Society (<ext-link ext-link-type="uri" xlink:href="https://lipidomicssociety.org/">https://lipidomicssociety.org/</ext-link>), along with various reports on pre-analytical processing, especially that from the International Ring Trial (<xref rid="R92" ref-type="bibr">Thompson et al., 2019</xref>), have highlighted recommendations for sample storage and freeze&#x02013;thaw cycling, as well as other critical considerations for the standardization of lipidomics workflows (<xref rid="R17" ref-type="bibr">Burla et al., 2018</xref>; <xref rid="R36" ref-type="bibr">Heiskanen et al., 2013</xref>; <xref rid="R49" ref-type="bibr">Kirwan et al., 2018</xref>; <xref rid="R76" ref-type="bibr">O&#x02019;Donnell et al., 2019</xref>). New bioinformatics resources capable of identifying oxidized lipids and enzymatic products such as phosphatidylmethanol lipid species in lipidomics datasets are emerging (<xref rid="R52" ref-type="bibr">Koelmel et al., 2017</xref>; <xref rid="R73" ref-type="bibr">Ni et al., 2017</xref>; <xref rid="R94" ref-type="bibr">Tsugawa et al., 2015</xref>) and could become an important complement in quality assurance/quality control in both targeted and untargeted analyses.</p><p id="P27">Community-wide guidelines are needed to establish best practices to reduce lipid degradation during sample preparation and storage, as there is limited consensus within the lipidomics field. In addition, rigorous studies that scrutinize the advantages and disadvantages of approaches to ensure lipid stability are needed. Further, the lipidomics community should expand the concept of lipid stability over the entire analytical workflow, which includes more comprehensive investigations into the gas phase instability of some lipid species, leading to in-source fragmentation and potentially skewed lipid profiles.</p><p id="P28">To this point, tt is important to include optimized steps across the entire lipidomics workflow (including mass spectrometric parameters) in laboratory SOP to ensure lipid stability, while limiting the implementation of unnecessary and/or impractical preventative strategies if the lipid(s) that are being interrogated do not require it. Nevertheless, participation in programs offered by the CDC, such as the LSP that ensure the accuracy and precision of select lipid measurements can aid in evaluating existing sample preparation methodologies. The procedures and approaches successfully used in the CDC and NIST programs can be adopted in untargeted lipidomics applications to ensure accuracy, reliability, and comparability in lipid measurements.</p></sec></sec></body><back><ack id="S16"><p id="P29">Disclaimer</p><p id="P30">Certain commercial equipment, instruments, or materials are identified in this paper to adequately specify the experimental procedures. Such identification does not imply recommendation or endorsement by the National Institute of Standards and Technology; nor does it imply that the materials or equipment identified are necessarily the best for the purpose. Furthermore, the content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Standards and Technology.</p><p id="P31">The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention/the Agency for Toxic Substances and Disease Registry. Use of trade names is for identification only and does not imply endorsement by the Centers for Disease Control and Prevention, the Public Health Service and the US Department of Health and Human Services.</p></ack><fn-group><fn fn-type="COI-statement" id="FN1"><p id="P32">Conflict of Interest</p><p id="P33">The authors declare that they have no conflict of interest.</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term>apo A-I</term><def><p id="P34">apolipoprotein A-I</p></def></def-item><def-item><term>apo B</term><def><p id="P35">apolipoprotein B</p></def></def-item><def-item><term>BHA</term><def><p id="P36">butylated hydroxyanisole</p></def></def-item><def-item><term>BHT</term><def><p id="P37">butylated hydroxytoluene</p></def></def-item><def-item><term>CDC</term><def><p id="P38">Centers for Disease Control and Prevention</p></def></def-item><def-item><term>CGMP</term><def><p id="P39">current good manufacturing practices</p></def></def-item><def-item><term>CRMLN</term><def><p id="P40">Cholesterol Reference Method Laboratory Network</p></def></def-item><def-item><term>FAQAP</term><def><p id="P41">fatty acids in human serum and plasma quality assurance program</p></def></def-item><def-item><term>FDA</term><def><p id="P42">Food and Drug Administration</p></def></def-item><def-item><term>HAMQAP</term><def><p id="P43">health assessment measurements quality assurance program</p></def></def-item><def-item><term>HDL-C</term><def><p id="P44">high-density lipoprotein cholesterol</p></def></def-item><def-item><term>IROA</term><def><p id="P45">isotopic ratio outlier analysis</p></def></def-item><def-item><term>LILY</term><def><p id="P46">lipidome isotope labeling of yeast</p></def></def-item><def-item><term>LSP</term><def><p id="P47">lipids standardization program</p></def></def-item><def-item><term>NIH</term><def><p id="P48">National Institutes of Health</p></def></def-item><def-item><term>NIST</term><def><p id="P49">National Institute of Standards and Technology</p></def></def-item><def-item><term>ODS</term><def><p id="P50">Office of Dietary Supplements</p></def></def-item><def-item><term>PEt</term><def><p id="P51">phosphatidylethanol</p></def></def-item><def-item><term>PG</term><def><p id="P52">propyl gallate</p></def></def-item><def-item><term>PLA</term><def><p id="P53">phospholipase</p></def></def-item><def-item><term>PLA<sub>1</sub></term><def><p id="P54">phospholipase A<sub>1</sub></p></def></def-item><def-item><term>PMe</term><def><p id="P55">phosphatidylmethanol</p></def></def-item><def-item><term>PMSF</term><def><p id="P56">phenylmethanesulfonyl fluoride</p></def></def-item><def-item><term>PUFA</term><def><p id="P57">polyunsaturated fatty acids</p></def></def-item><def-item><term>QA</term><def><p id="P58">quality assurance</p></def></def-item><def-item><term>QC</term><def><p id="P59">quality control</p></def></def-item><def-item><term>SOP</term><def><p id="P60">standard operating procedures</p></def></def-item><def-item><term>SRM</term><def><p id="P61">standard reference material</p></def></def-item><def-item><term>TBHQ</term><def><p id="P62">tertiary butylhydroquinone</p></def></def-item><def-item><term>TC</term><def><p id="P63">total cholesterol</p></def></def-item><def-item><term>TAG</term><def><p id="P64">triacylglycerol</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="R1"><mixed-citation publication-type="journal"><name><surname>Abuja</surname><given-names>PM</given-names></name>, <name><surname>Ehrhart</surname><given-names>F</given-names></name>, <name><surname>Schoen</surname><given-names>U</given-names></name>, <name><surname>Schmidt</surname><given-names>T</given-names></name>, <name><surname>Stracke</surname><given-names>F</given-names></name>, <name><surname>Dallmann</surname><given-names>G</given-names></name>, &#x02026; <name><surname>Zatloukal</surname><given-names>K</given-names></name> (<year>2015</year>) <article-title>Alterations in human liver metabolome during prolonged cryostorage</article-title>. <source>Journal of Proteome Research</source>, <volume>14</volume>:<fpage>2758</fpage>&#x02013;<lpage>2768</lpage>.<pub-id pub-id-type="pmid">26036795</pub-id></mixed-citation></ref><ref id="R2"><mixed-citation publication-type="journal"><name><surname>Ademowo</surname><given-names>OS</given-names></name>, <name><surname>Dias</surname><given-names>HKI</given-names></name>, <name><surname>Burton</surname><given-names>DGA</given-names></name>, &#x00026; <name><surname>Griffiths</surname><given-names>HR</given-names></name> (<year>2017</year>) Lipid (per) <article-title>oxidation in mitochondria: An emerging target in the ageing process</article-title>? <source>Biogerontology</source>, <volume>18</volume>:<fpage>859</fpage>&#x02013;<lpage>879</lpage>.<pub-id pub-id-type="pmid">28540446</pub-id></mixed-citation></ref><ref id="R3"><mixed-citation publication-type="journal"><name><surname>Aiello</surname><given-names>EJ</given-names></name>, <name><surname>Tworoger</surname><given-names>SS</given-names></name>, <name><surname>Yasui</surname><given-names>Y</given-names></name>, <name><surname>Stanczyk</surname><given-names>FZ</given-names></name>, <name><surname>Potter</surname><given-names>J</given-names></name>, <name><surname>Ulrich</surname><given-names>CM</given-names></name>, &#x02026; <name><surname>McTiernan</surname><given-names>A</given-names></name> (<year>2005</year>) <article-title>Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women</article-title>. <source>Cancer Epidemiology, Biomarkers &#x00026; Prevention</source>, <volume>14</volume>:<fpage>1411</fpage>&#x02013;<lpage>1417</lpage>.</mixed-citation></ref><ref id="R4"><mixed-citation publication-type="journal"><name><surname>Anton</surname><given-names>G</given-names></name>, <name><surname>Wilson</surname><given-names>R</given-names></name>, <name><surname>Yu</surname><given-names>Z-H</given-names></name>, <name><surname>Prehn</surname><given-names>C</given-names></name>, <name><surname>Zukunft</surname><given-names>S</given-names></name>, <name><surname>Adamski</surname><given-names>J</given-names></name>, . <name><surname>Waldenberger</surname><given-names>M</given-names></name> (<year>2015</year>) <article-title>Pre-analytical sample quality: Metabolite ratios as an intrinsic marker for prolonged room temperature exposure of serum samples</article-title>. <source>PLoS One</source>, <volume>10</volume>:<fpage>e0121495</fpage>.<pub-id pub-id-type="pmid">25823017</pub-id></mixed-citation></ref><ref id="R5"><mixed-citation publication-type="journal"><name><surname>Aoki</surname><given-names>J</given-names></name>, <name><surname>Inoue</surname><given-names>A</given-names></name>, &#x00026; <name><surname>Okudaira</surname><given-names>S</given-names></name> (<year>2008</year>) <article-title>Two pathways for lysophosphatidic acid production</article-title>. <source>Biochimica et Biophysica Acta</source>, <volume>1781</volume>:<fpage>513</fpage>&#x02013;<lpage>518</lpage>.<pub-id pub-id-type="pmid">18621144</pub-id></mixed-citation></ref><ref id="R6"><mixed-citation publication-type="journal"><name><surname>Aoki</surname><given-names>J</given-names></name>, <name><surname>Taira</surname><given-names>A</given-names></name>, <name><surname>Takanezawa</surname><given-names>Y</given-names></name>, <name><surname>Kishi</surname><given-names>Y</given-names></name>, <name><surname>Hama</surname><given-names>K</given-names></name>, <name><surname>Kishimoto</surname><given-names>T</given-names></name>, &#x02026; <name><surname>Arai</surname><given-names>H</given-names></name> (<year>2002</year>) <article-title>Serum lysophosphatidic acid is produced through diverse phospholipase pathways</article-title>. <source>The Journal of Biological Chemistry</source>, <volume>277</volume>:<fpage>48737</fpage>&#x02013;<lpage>48744</lpage>.<pub-id pub-id-type="pmid">12354767</pub-id></mixed-citation></ref><ref id="R7"><mixed-citation publication-type="journal"><name><surname>Aristizabal-Henao</surname><given-names>JJ</given-names></name>, <name><surname>Fernandes</surname><given-names>MF</given-names></name>, <name><surname>Duncan</surname><given-names>RE</given-names></name>, &#x00026; <name><surname>Stark</surname><given-names>KD</given-names></name> (<year>2019</year>) <article-title>Development of a rapid ultra high-performance liquid chromatography/tandem mass spectrometry method for the analysis of sn-1 and sn-2 lysophosphatidic acid Regioisomers in mouse plasma</article-title>. <source>Lipids</source>, <volume>54</volume>:<fpage>479</fpage>&#x02013;<lpage>486</lpage>.<pub-id pub-id-type="pmid">31236951</pub-id></mixed-citation></ref><ref id="R8"><mixed-citation publication-type="journal"><name><surname>Arzu</surname><given-names>K</given-names></name>, <name><surname>Canan</surname><given-names>T</given-names></name>, <name><surname>Sevilay</surname><given-names>S</given-names></name>, <name><surname>Simal Koksal</surname><given-names>C</given-names></name>, <name><surname>Ezgi Co&#x000a7;kun</surname><given-names>Y</given-names></name>, <name><surname>Fatih</surname><given-names>D</given-names></name>, &#x00026; <name><surname>Turan</surname><given-names>T</given-names></name> (<year>2019</year>) <article-title>Comparison of some biochemical tests in different blood collection tubes in hemodialysis patients</article-title>. <source>Turkish Journal of Biochemistry</source>, <volume>45</volume>:<fpage>26</fpage>&#x02013;<lpage>36</lpage>.</mixed-citation></ref><ref id="R9"><mixed-citation publication-type="journal"><name><surname>Barber</surname><given-names>CA</given-names></name>, <name><surname>Benner</surname><given-names>BA</given-names></name>, <name><surname>Thomas</surname><given-names>JB</given-names></name>, <name><surname>Burdette</surname><given-names>CQ</given-names></name>, <name><surname>Camara</surname><given-names>J</given-names></name>, <name><surname>Long</surname><given-names>S</given-names></name>, <name><surname>Murray</surname><given-names>JA</given-names></name>, <name><surname>Phillips</surname><given-names>MM</given-names></name>, <name><surname>Place</surname><given-names>BJ</given-names></name>, <name><surname>Rimmer</surname><given-names>CA</given-names></name>, <name><surname>Wood</surname><given-names>LJ</given-names></name>, <name><surname>Yu</surname><given-names>L</given-names></name>, <name><surname>Chinthalapati</surname><given-names>SKR</given-names></name>, &#x00026; <name><surname>Tai</surname><given-names>SS-C</given-names></name> (<year>2018</year>) <source>Health assessment measurements quality assurance program: Exercise 1 final report</source>. <comment>NISTIR 8237.</comment> pp. <fpage>1</fpage>&#x02013;<lpage>330</lpage></mixed-citation></ref><ref id="R10"><mixed-citation publication-type="book"><name><surname>Blanco</surname><given-names>A</given-names></name>, &#x00026; <name><surname>Blanco</surname><given-names>G</given-names></name> (<year>2017</year>) <chapter-title>Antioxidants</chapter-title> In <name><surname>Blanco</surname><given-names>A</given-names></name> &#x00026; <name><surname>Blanco</surname><given-names>G</given-names></name> (Eds.), <source>Medical Biochemistry</source> (PP. <fpage>205</fpage>&#x02013;<lpage>214</lpage>). <publisher-loc>England</publisher-loc>: <publisher-name>Academic Press</publisher-name>.</mixed-citation></ref><ref id="R11"><mixed-citation publication-type="journal"><name><surname>Bowden</surname><given-names>JA</given-names></name>, <name><surname>Albert</surname><given-names>CJ</given-names></name>, <name><surname>Barnaby</surname><given-names>OS</given-names></name>, &#x00026; <name><surname>Ford</surname><given-names>DA</given-names></name> (<year>2011</year>) <article-title>Analysis of cholesteryl esters and diacylglycerols using lithiated adducts and electrospray ionization-tandem mass spectrometry</article-title>. <source>Analytical Biochemistry</source>, <volume>417</volume>:<fpage>202</fpage>&#x02013;<lpage>210</lpage>.<pub-id pub-id-type="pmid">21741949</pub-id></mixed-citation></ref><ref id="R12"><mixed-citation publication-type="book"><name><surname>Bowden</surname><given-names>JA</given-names></name>, <name><surname>Heckert</surname><given-names>A</given-names></name>, <name><surname>Ulmer</surname><given-names>CZ</given-names></name>, &#x00026; <name><surname>Jones</surname><given-names>CM</given-names></name> (<year>2017b</year>) <source>Lipid concentrations in standard reference material (SRM) 1950: Results from an Interlaboratory Comparison Exercise for Lipidomics</source>. <publisher-name>NISTIR</publisher-name>
<volume>8185</volume>: <fpage>1</fpage>&#x02013;<lpage>451</lpage></mixed-citation></ref><ref id="R13"><mixed-citation publication-type="journal"><name><surname>Bowden</surname><given-names>JA</given-names></name>, <name><surname>Heckert</surname><given-names>A</given-names></name>, <name><surname>Ulmer</surname><given-names>CZ</given-names></name>, <name><surname>Jones</surname><given-names>CM</given-names></name>, <name><surname>Koelmel</surname><given-names>JP</given-names></name>, <name><surname>Abdullah</surname><given-names>L</given-names></name>, &#x02026; <name><surname>Zhou</surname><given-names>S</given-names></name> (<year>2017a</year>) <article-title>Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using SRM 1950-metabolites in frozen human plasma</article-title>. <source>Journal of Lipid Research</source>, <volume>58</volume>:<fpage>2275</fpage>&#x02013;<lpage>2288</lpage>.<pub-id pub-id-type="pmid">28986437</pub-id></mixed-citation></ref><ref id="R14"><mixed-citation publication-type="journal"><name><surname>Bowden</surname><given-names>JA</given-names></name>, <name><surname>Ulmer</surname><given-names>CZ</given-names></name>, <name><surname>Jones</surname><given-names>CM</given-names></name>, <name><surname>Koelmel</surname><given-names>JP</given-names></name>, &#x00026; <name><surname>Yost</surname><given-names>RA</given-names></name> (<year>2018</year>) <article-title>NIST lipidomics workflow questionnaire: An assessment of community-wide methodologies and perspectives</article-title>. <source>Metabolomics</source>, <volume>14</volume>:<fpage>53</fpage>.<pub-id pub-id-type="pmid">30830346</pub-id></mixed-citation></ref><ref id="R15"><mixed-citation publication-type="journal"><name><surname>Bowen</surname><given-names>RAR</given-names></name>, &#x00026; <name><surname>Remaley</surname><given-names>AT</given-names></name> (<year>2014</year>) <article-title>Interferences from blood collection tube components on clinical chemistry assays</article-title>. <source>Biochemia Medica (Zagreb)</source>, <volume>24</volume>:<fpage>31</fpage>&#x02013;<lpage>44</lpage>.</mixed-citation></ref><ref id="R16"><mixed-citation publication-type="journal"><name><surname>Bozza</surname><given-names>PT</given-names></name>, &#x00026; <name><surname>Viola</surname><given-names>JP</given-names></name> (<year>2010</year>) <article-title>Lipid droplets in inflammation and cancer</article-title>. <source>Prostaglandins, Leukotrienes, and Essential Fatty Acids</source>, <volume>82</volume>:<fpage>243</fpage>&#x02013;<lpage>250</lpage>.</mixed-citation></ref><ref id="R17"><mixed-citation publication-type="journal"><name><surname>Burla</surname><given-names>B</given-names></name>, <name><surname>Arita</surname><given-names>M</given-names></name>, <name><surname>Arita</surname><given-names>M</given-names></name>, <name><surname>Bendt</surname><given-names>AK</given-names></name>, <name><surname>Cazenave-Gassiot</surname><given-names>A</given-names></name>, <name><surname>Dennis</surname><given-names>EA</given-names></name>, &#x02026; <name><surname>Wenk</surname><given-names>MR</given-names></name> (<year>2018</year>) <article-title>MS-based lipidomics of human blood plasma: A community-initiated position paper to develop accepted guidelines</article-title>. <source>Journal of Lipid Research</source>, <volume>59</volume>: <fpage>2001</fpage>&#x02013;<lpage>2017</lpage>.<pub-id pub-id-type="pmid">30115755</pub-id></mixed-citation></ref><ref id="R18"><mixed-citation publication-type="book"><name><surname>Burtis</surname><given-names>CA</given-names></name>, <name><surname>Ashwood</surname><given-names>ER</given-names></name>, <name><surname>Bruns</surname><given-names>DE</given-names></name>, &#x00026; <name><surname>Tietz</surname><given-names>NW</given-names></name> (<year>2013</year>) <source>Tietz textbook of clinical chemistry and molecular diagnostics</source>. <publisher-loc>St. Louis, MO</publisher-loc>: <publisher-name>Saunders</publisher-name>.</mixed-citation></ref><ref id="R19"><mixed-citation publication-type="journal"><name><surname>Canakci</surname><given-names>M</given-names></name> (<year>2007</year>) <article-title>The potential of restaurant waste lipids as biodiesel feedstocks</article-title>. <source>Bioresource Technology</source>, <volume>98</volume>:<fpage>183</fpage>&#x02013;<lpage>190</lpage>.<pub-id pub-id-type="pmid">16412631</pub-id></mixed-citation></ref><ref id="R20"><mixed-citation publication-type="journal"><name><surname>Carmella</surname><given-names>SG</given-names></name>, <name><surname>Heskin</surname><given-names>AK</given-names></name>, <name><surname>Tang</surname><given-names>MK</given-names></name>, <name><surname>Jensen</surname><given-names>J</given-names></name>, <name><surname>Luo</surname><given-names>X</given-names></name>, <name><surname>Le</surname><given-names>CT</given-names></name>, &#x02026; <name><surname>Hecht</surname><given-names>SS</given-names></name> (<year>2019</year>) <article-title>Longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammation</article-title>. <source>PLoS One</source>, <volume>14</volume>:<fpage>e0215853</fpage>.<pub-id pub-id-type="pmid">31022220</pub-id></mixed-citation></ref><ref id="R21"><mixed-citation publication-type="book"><collab>Centers for Disease Control and Prevention</collab>. (<year>2018</year>) <source>Improving the Collection and Management of Human Samples Used for Measuring Environmental Chemicals and Nutrition Indicators - Version 1.3, Sciences USDoHaH, Editor</source>. <publisher-name>National Center for Environmental Health: Division of Laboratory Sciences</publisher-name> pp. <fpage>1</fpage>&#x02013;<lpage>24</lpage>.</mixed-citation></ref><ref id="R22"><mixed-citation publication-type="journal"><name><surname>Dalle-Donne</surname><given-names>I</given-names></name>, <name><surname>Rossi</surname><given-names>R</given-names></name>, <name><surname>Colombo</surname><given-names>R</given-names></name>, <name><surname>Giustarini</surname><given-names>D</given-names></name>, &#x00026; <name><surname>Milzani</surname><given-names>A</given-names></name> (<year>2006</year>) <article-title>Biomarkers of oxidative damage in human disease</article-title>. <source>Clinical Chemistry</source>, <volume>52</volume>:<fpage>601</fpage>&#x02013;<lpage>623</lpage>.<pub-id pub-id-type="pmid">16484333</pub-id></mixed-citation></ref><ref id="R23"><mixed-citation publication-type="journal"><name><surname>De Caterina</surname><given-names>R</given-names></name> (<year>2011</year>) <article-title>N-3 fatty acids in cardiovascular disease</article-title>. <source>The New England Journal of Medicine</source>, <volume>364</volume>:<fpage>2439</fpage>&#x02013;<lpage>2450</lpage>.<pub-id pub-id-type="pmid">21696310</pub-id></mixed-citation></ref><ref id="R24"><mixed-citation publication-type="journal"><name><surname>Dorow</surname><given-names>J</given-names></name>, <name><surname>Becker</surname><given-names>S</given-names></name>, <name><surname>Kortz</surname><given-names>L</given-names></name>, <name><surname>Thiery</surname><given-names>J</given-names></name>, <name><surname>Hauschildt</surname><given-names>S</given-names></name>, &#x00026; <name><surname>Ceglarek</surname><given-names>U</given-names></name> (<year>2016</year>) <article-title>Preanalytical investigation of polyunsaturated fatty acids and eicosanoids in human plasma by liquid chromatography-tandem mass spectrometry</article-title>. <source>Biopreservation and Biobanking</source>, <volume>14</volume>:<fpage>107</fpage>&#x02013;<lpage>113</lpage>.<pub-id pub-id-type="pmid">26886177</pub-id></mixed-citation></ref><ref id="R25"><mixed-citation publication-type="journal"><name><surname>Fernandis</surname><given-names>AZ</given-names></name>, &#x00026; <name><surname>Wenk</surname><given-names>MR</given-names></name> (<year>2009</year>) <article-title>Lipid-based biomarkers for cancer</article-title>. <source>Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences</source>, <volume>877</volume>:<fpage>2830</fpage>&#x02013;<lpage>2835</lpage>.<pub-id pub-id-type="pmid">19570730</pub-id></mixed-citation></ref><ref id="R26"><mixed-citation publication-type="journal"><name><surname>Ferrero</surname><given-names>ME</given-names></name> (<year>2016</year>) <article-title>Rationale for the successful management of EDTA chelation therapy in human burden by toxic metals</article-title>. <source>BioMed Research International</source>, <volume>2016</volume>:<fpage>8274504</fpage>&#x02013;<lpage>8274504</lpage>.<pub-id pub-id-type="pmid">27896275</pub-id></mixed-citation></ref><ref id="R27"><mixed-citation publication-type="journal"><name><surname>Fung</surname><given-names>TT</given-names></name>, <name><surname>Rimm</surname><given-names>EB</given-names></name>, <name><surname>Spiegelman</surname><given-names>D</given-names></name>, <name><surname>Rifai</surname><given-names>N</given-names></name>, <name><surname>Tofler</surname><given-names>GH</given-names></name>, <name><surname>Willett</surname><given-names>WC</given-names></name>, &#x00026; <name><surname>Hu</surname><given-names>FB</given-names></name> (<year>2001</year>) <article-title>Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk</article-title>. <source>The American Journal of Clinical Nutrition</source>, <volume>73</volume>:<fpage>61</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="pmid">11124751</pub-id></mixed-citation></ref><ref id="R28"><mixed-citation publication-type="journal"><name><surname>Furberg</surname><given-names>AS</given-names></name>, <name><surname>Jasienska</surname><given-names>G</given-names></name>, <name><surname>Bjurstam</surname><given-names>N</given-names></name>, <name><surname>Toijesen</surname><given-names>PA</given-names></name>, <name><surname>Emaus</surname><given-names>A</given-names></name>, <name><surname>Lipson</surname><given-names>SF</given-names></name>, &#x02026; <name><surname>Thune</surname><given-names>I</given-names></name> (<year>2005</year>) <article-title>Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study</article-title>. <source>Cancer Epidemiology, Biomarkers &#x00026; Prevention</source>, <volume>14</volume>:<fpage>33</fpage>&#x02013;<lpage>40</lpage>.</mixed-citation></ref><ref id="R29"><mixed-citation publication-type="journal"><name><surname>Fusch</surname><given-names>G</given-names></name>, <name><surname>Rochow</surname><given-names>N</given-names></name>, <name><surname>Choi</surname><given-names>A</given-names></name>, <name><surname>Fusch</surname><given-names>S</given-names></name>, <name><surname>Poeschl</surname><given-names>S</given-names></name>, <name><surname>Ubah</surname><given-names>AO</given-names></name>, &#x02026; <name><surname>Fusch</surname><given-names>C</given-names></name> (<year>2015</year>) <article-title>Rapid measurement of macronutrients in breast milk: How reliable are infrared milk analyzers</article-title>? <source>Clinical Nutrition (Edinburgh, Scotland)</source>, <volume>34</volume>:<fpage>465</fpage>&#x02013;<lpage>476</lpage>.</mixed-citation></ref><ref id="R30"><mixed-citation publication-type="journal"><name><surname>Gil</surname><given-names>A</given-names></name>, <name><surname>Siegel</surname><given-names>D</given-names></name>, <name><surname>Permentier</surname><given-names>H</given-names></name>, <name><surname>Reijngoud</surname><given-names>DJ</given-names></name>, <name><surname>Dekker</surname><given-names>F</given-names></name>, &#x00026; <name><surname>Bischoff</surname><given-names>R</given-names></name> (<year>2015</year>) <article-title>Stability of energy metabolites-an often over-looked issue in metabolomics studies: A review</article-title>. <source>Electrophoresis</source>, <volume>36</volume>:<fpage>2156</fpage>&#x02013;<lpage>2169</lpage>.<pub-id pub-id-type="pmid">25959207</pub-id></mixed-citation></ref><ref id="R31"><mixed-citation publication-type="book"><name><surname>Gil</surname><given-names>A</given-names></name>, <name><surname>Zhang</surname><given-names>W</given-names></name>, <name><surname>Wolters</surname><given-names>JC</given-names></name>, <name><surname>Permentier</surname><given-names>H</given-names></name>, <name><surname>Horvatovich</surname><given-names>P</given-names></name>, <name><surname>Rebecca Heiner-Fokkema</surname><given-names>M</given-names></name>, &#x02026; <name><surname>Bischoff</surname><given-names>R</given-names></name> (<year>2019</year>) <chapter-title>Omics | Lipdomics and its pitfalls during the pre-analytical stage</chapter-title> In <name><surname>Worsfold</surname><given-names>P</given-names></name>, <name><surname>Poole</surname><given-names>C</given-names></name>, <name><surname>Townshend</surname><given-names>A</given-names></name>, &#x00026; <name><surname>Mir&#x000f3;</surname><given-names>M</given-names></name> (Eds.), <source>Encyclopedia of analytical science</source> (<edition>3rd ed.</edition>). <publisher-loc>Oxford, England</publisher-loc>: <publisher-name>Academic Press</publisher-name>.</mixed-citation></ref><ref id="R32"><mixed-citation publication-type="journal"><name><surname>Gonzalez-Covarrubias</surname><given-names>V</given-names></name>, <name><surname>Dane</surname><given-names>A</given-names></name>, <name><surname>Hankemeier</surname><given-names>T</given-names></name>, &#x00026; <name><surname>Vreeken</surname><given-names>R</given-names></name> (<year>2013</year>) <article-title>The influence of citrate, EDTA, and heparin anticoagulants to human plasma LC&#x02013;MS lipidomic profiling</article-title>. <source>Metabolomics</source>, <volume>9</volume>: <fpage>337</fpage>&#x02013;<lpage>348</lpage>.</mixed-citation></ref><ref id="R33"><mixed-citation publication-type="journal"><name><surname>Haid</surname><given-names>M</given-names></name>, <name><surname>Muschet</surname><given-names>C</given-names></name>, <name><surname>Wahl</surname><given-names>S</given-names></name>, <name><surname>Romisch-Margl</surname><given-names>W</given-names></name>, <name><surname>Prehn</surname><given-names>C</given-names></name>, <name><surname>Moller</surname><given-names>G</given-names></name>, &#x00026; <name><surname>Adamski</surname><given-names>J</given-names></name> (<year>2018</year>) <article-title>Long-term stability of human plasma metabolites during storage at &#x02212;80 degrees C</article-title>. <source>Journal of Proteome Research</source>, <volume>17</volume>:<fpage>203</fpage>&#x02013;<lpage>211</lpage>.<pub-id pub-id-type="pmid">29064256</pub-id></mixed-citation></ref><ref id="R34"><mixed-citation publication-type="journal"><name><surname>Halliwell</surname><given-names>B</given-names></name> (<year>2000</year>) <article-title>Lipid peroxidation, antioxidants and cardiovascular disease: How should we move forward</article-title>? <source>Cardiovascular Research</source>, <volume>47</volume>:<fpage>410</fpage>&#x02013;<lpage>418</lpage>.<pub-id pub-id-type="pmid">10963714</pub-id></mixed-citation></ref><ref id="R35"><mixed-citation publication-type="journal"><name><surname>Han</surname><given-names>C</given-names></name>, <name><surname>Zhang</surname><given-names>HT</given-names></name>, <name><surname>Du</surname><given-names>L</given-names></name>, <name><surname>Liu</surname><given-names>X</given-names></name>, <name><surname>Jing</surname><given-names>J</given-names></name>, <name><surname>Zhao</surname><given-names>X</given-names></name>, &#x02026; <name><surname>Tian</surname><given-names>B</given-names></name> (<year>2005</year>) <article-title>Serum levels of leptin, insulin, and lipids in relation to breast cancer in China</article-title>. <source>Endocrine</source>, <volume>26</volume>:<fpage>19</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="pmid">15805581</pub-id></mixed-citation></ref><ref id="R36"><mixed-citation publication-type="journal"><name><surname>Heiskanen</surname><given-names>LA</given-names></name>, <name><surname>Suoniemi</surname><given-names>M</given-names></name>, <name><surname>Ta</surname><given-names>HX</given-names></name>, <name><surname>Tarasov</surname><given-names>K</given-names></name>, &#x00026; <name><surname>Ekroos</surname><given-names>K</given-names></name> (<year>2013</year>) <article-title>Long-term performance and stability of molecular shotgun lipidomic analysis of human plasma samples</article-title>. <source>Analytical Chemistry</source>, <volume>85</volume>:<fpage>8757</fpage>&#x02013;<lpage>8763</lpage>.<pub-id pub-id-type="pmid">23919256</pub-id></mixed-citation></ref><ref id="R37"><mixed-citation publication-type="journal"><name><surname>Hennebelle</surname><given-names>M</given-names></name>, <name><surname>Metherel</surname><given-names>AH</given-names></name>, <name><surname>Kitson</surname><given-names>AP</given-names></name>, <name><surname>Otoki</surname><given-names>Y</given-names></name>, <name><surname>Yang</surname><given-names>J</given-names></name>, <name><surname>Lee</surname><given-names>KSS</given-names></name>, &#x02026; <name><surname>Taha</surname><given-names>AY</given-names></name> (<year>2019</year>) <article-title>Brain oxylipin concentrations following hypercapnia/ischemia: Effects of brain dissection and dissection time</article-title>. <source>Journal of Lipid Research</source>, <volume>60</volume>:<fpage>671</fpage>&#x02013;<lpage>682</lpage>.<pub-id pub-id-type="pmid">30463986</pub-id></mixed-citation></ref><ref id="R38"><mixed-citation publication-type="journal"><name><surname>Hess</surname><given-names>PS</given-names></name>, &#x00026; <name><surname>O&#x02019;Hare</surname><given-names>GA</given-names></name> (<year>1950</year>) <article-title>Oxidation of linseed oil</article-title>. <source>Industrial &#x00026; Engineering Chemistry</source>, <volume>42</volume>:<fpage>1424</fpage>&#x02013;<lpage>1431</lpage>.</mixed-citation></ref><ref id="R39"><mixed-citation publication-type="journal"><name><surname>Hill-Kapturczak</surname><given-names>N</given-names></name>, <name><surname>Dougherty</surname><given-names>DM</given-names></name>, <name><surname>Roache</surname><given-names>JD</given-names></name>, <name><surname>Karns-Wright</surname><given-names>TE</given-names></name>, &#x00026; <name><surname>Javors</surname><given-names>MA</given-names></name> (<year>2018</year>) <article-title>Differences in the synthesis and elimination of phosphatidylethanol 16:0/18:1 and 16:0/18:2 after acute doses of alcohol</article-title>. <source>Alcoholism, Clinical and Experimental Research</source>, <volume>42</volume>:<fpage>851</fpage>&#x02013;<lpage>860</lpage>.</mixed-citation></ref><ref id="R40"><mixed-citation publication-type="journal"><name><surname>Hinterwirth</surname><given-names>H</given-names></name>, <name><surname>Stegemann</surname><given-names>C</given-names></name>, &#x00026; <name><surname>Mayr</surname><given-names>M</given-names></name> (<year>2014</year>) <article-title>Lipidomics: Quest for molecular lipid biomarkers in cardiovascular disease</article-title>. <source>Circulation. Cardiovascular Genetics</source>, <volume>7</volume>:<fpage>941</fpage>&#x02013;<lpage>954</lpage>.<pub-id pub-id-type="pmid">25516624</pub-id></mixed-citation></ref><ref id="R41"><mixed-citation publication-type="journal"><name><surname>Hjm Jansen</surname><given-names>E</given-names></name> (<year>2014</year>) <article-title>Long term stability of parameters of lipid metabolism in frozen human serum: Triglycerides, free fatty acids, Total-, HDL- and LDL-cholesterol, apolipoprotein-A1 and B</article-title>. <source>Journal of Molecular Biomarkers &#x00026; Diagnosis</source>, <volume>5</volume>:<fpage>1</fpage>&#x02013;<lpage>5</lpage>.</mixed-citation></ref><ref id="R42"><mixed-citation publication-type="journal"><name><surname>Holl</surname><given-names>K</given-names></name>, <name><surname>Lundin</surname><given-names>E</given-names></name>, <name><surname>Kaasila</surname><given-names>M</given-names></name>, <name><surname>Grankvist</surname><given-names>K</given-names></name>, <name><surname>Afanasyeva</surname><given-names>Y</given-names></name>, <name><surname>Hallmans</surname><given-names>G</given-names></name>, &#x02026; <name><surname>Lukanova</surname><given-names>A</given-names></name> (<year>2008</year>) <article-title>Effect of long-term storage on hormone measurements in samples from pregnant women: The experience of the Finnish maternity cohort</article-title>. <source>Acta Oncologica</source>, <volume>47</volume>:<fpage>406</fpage>&#x02013;<lpage>412</lpage>.<pub-id pub-id-type="pmid">17891670</pub-id></mixed-citation></ref><ref id="R43"><mixed-citation publication-type="journal"><name><surname>Ishikawa</surname><given-names>M</given-names></name>, <name><surname>Maekawa</surname><given-names>K</given-names></name>, <name><surname>Saito</surname><given-names>K</given-names></name>, <name><surname>Senoo</surname><given-names>Y</given-names></name>, <name><surname>Urata</surname><given-names>M</given-names></name>, <name><surname>Murayama</surname><given-names>M</given-names></name>, &#x02026; <name><surname>Saito</surname><given-names>Y</given-names></name> (<year>2014</year>) <article-title>Plasma and serum lipidomics of healthy white adults shows characteristic profiles by subjects&#x02019; gender and age</article-title>. <source>PLoS One</source>, <volume>9</volume>:<fpage>e91806</fpage>.<pub-id pub-id-type="pmid">24632803</pub-id></mixed-citation></ref><ref id="R44"><mixed-citation publication-type="journal"><name><surname>Jane Ellis</surname><given-names>M</given-names></name>, <name><surname>Livesey</surname><given-names>JH</given-names></name>, &#x00026; <name><surname>Evans</surname><given-names>MJ</given-names></name> (<year>2003</year>) <article-title>Hormone stability in human whole blood</article-title>. <source>Clinical Biochemistry</source>, <volume>36</volume>:<fpage>109</fpage>&#x02013;<lpage>112</lpage>.<pub-id pub-id-type="pmid">12633759</pub-id></mixed-citation></ref><ref id="R45"><mixed-citation publication-type="journal"><name><surname>Jones</surname><given-names>ME</given-names></name>, <name><surname>Folkerd</surname><given-names>EJ</given-names></name>, <name><surname>Doody</surname><given-names>DA</given-names></name>, <name><surname>Iqbal</surname><given-names>J</given-names></name>, <name><surname>Dowsett</surname><given-names>M</given-names></name>, <name><surname>Ashworth</surname><given-names>A</given-names></name>, &#x00026; <name><surname>Swerdlow</surname><given-names>AJ</given-names></name> (<year>2007</year>) <article-title>Effect of delays in processing blood samples on measured endogenous plasma sex hormone levels in women</article-title>. <source>Cancer Epidemiology, Biomarkers &#x00026; Prevention</source>, <volume>16</volume>:<fpage>1136</fpage>&#x02013;<lpage>1139</lpage>.</mixed-citation></ref><ref id="R46"><mixed-citation publication-type="journal"><name><surname>Kamlage</surname><given-names>B</given-names></name>, <name><surname>Maldonado</surname><given-names>SG</given-names></name>, <name><surname>Bethan</surname><given-names>B</given-names></name>, <name><surname>Peter</surname><given-names>E</given-names></name>, <name><surname>Schmitz</surname><given-names>O</given-names></name>, <name><surname>Liebenberg</surname><given-names>V</given-names></name>, &#x00026; <name><surname>Schatz</surname><given-names>P</given-names></name> (<year>2014</year>) <article-title>Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling</article-title>. <source>Clinical Chemisty</source>, <volume>60</volume>:<fpage>399</fpage>&#x02013;<lpage>412</lpage>.</mixed-citation></ref><ref id="R47"><mixed-citation publication-type="journal"><name><surname>Kensova</surname><given-names>R</given-names></name>, <name><surname>Hynek</surname><given-names>D</given-names></name>, <name><surname>Kynicky</surname><given-names>J</given-names></name>, <name><surname>Konecna</surname><given-names>M</given-names></name>, <name><surname>Eckschlager</surname><given-names>T</given-names></name>, <name><surname>Adam</surname><given-names>V</given-names></name>, &#x02026; <name><surname>Kizek</surname><given-names>R</given-names></name> (<year>2014</year>) <article-title>Determination of metal ions in the plasma of children with tumour diseases by differential pulse voltammetry</article-title>. <source>International Journal of Electrochemical Science</source>, <volume>9</volume>:<fpage>4675</fpage>&#x02013;<lpage>4691</lpage>.</mixed-citation></ref><ref id="R48"><mixed-citation publication-type="journal"><name><surname>Kirkwood</surname><given-names>JS</given-names></name>, <name><surname>Maier</surname><given-names>C</given-names></name>, &#x00026; <name><surname>Stevens</surname><given-names>JF</given-names></name> (<year>2013</year>) <article-title>Simultaneous, untargeted metabolic profiling of polar and nonpolar metabolites by LC-Q-TOF mass spectrometry</article-title>. <source>Current Protocols in Toxicology</source>, <volume>4</volume>:<fpage>4.39</fpage>&#x02013;<lpage>34.39</lpage>.</mixed-citation></ref><ref id="R49"><mixed-citation publication-type="journal"><name><surname>Kirwan</surname><given-names>JA</given-names></name>, <name><surname>Brennan</surname><given-names>L</given-names></name>, <name><surname>Broadhurst</surname><given-names>D</given-names></name>, <name><surname>Fiehn</surname><given-names>O</given-names></name>, <name><surname>Cascante</surname><given-names>M</given-names></name>, <name><surname>Dunn</surname><given-names>WB</given-names></name>, &#x02026; <name><surname>Velagapudi</surname><given-names>V</given-names></name> (<year>2018</year>) <article-title>Preanalytical processing and biobanking procedures of biological samples for metabolomics research: A white paper, community perspective (for &#x0201c;precision medicine and Pharmacometabolomics task group&#x0201d;-the metabolomics society initiative)</article-title>. <source>Clinical Chemistry</source>, <volume>64</volume>:<fpage>1158</fpage>&#x02013;<lpage>1182</lpage>.<pub-id pub-id-type="pmid">29921725</pub-id></mixed-citation></ref><ref id="R50"><mixed-citation publication-type="journal"><name><surname>Koelmel</surname><given-names>JP</given-names></name>, <name><surname>Cochran</surname><given-names>JA</given-names></name>, <name><surname>Ulmer</surname><given-names>CZ</given-names></name>, <name><surname>Levy</surname><given-names>AJ</given-names></name>, <name><surname>Patterson</surname><given-names>RE</given-names></name>, <name><surname>Olsen</surname><given-names>BC</given-names></name>, &#x02026; <name><surname>Garrett</surname><given-names>TJ</given-names></name> (<year>2019</year>) <article-title>Software tool for internal standard based normalization of lipids, and effect of data-processing strategies on resulting values</article-title>. <source>BMC Bioinformatics</source>, <volume>20</volume>:<fpage>217</fpage>.<pub-id pub-id-type="pmid">31035918</pub-id></mixed-citation></ref><ref id="R51"><mixed-citation publication-type="journal"><name><surname>Koelmel</surname><given-names>JP</given-names></name>, <name><surname>Jones</surname><given-names>CM</given-names></name>, <name><surname>Ulmer</surname><given-names>CZ</given-names></name>, <name><surname>Garrett</surname><given-names>TJ</given-names></name>, <name><surname>Yost</surname><given-names>RA</given-names></name>, <name><surname>Schock</surname><given-names>TB</given-names></name>, &#x00026; <name><surname>Bowden</surname><given-names>JA</given-names></name> (<year>2018</year>) <article-title>Examining heat treatment for stabilization of the lipidome</article-title>. <source>Bioanalysis</source>, <volume>10</volume>:<fpage>291</fpage>&#x02013;<lpage>305</lpage>.<pub-id pub-id-type="pmid">29451398</pub-id></mixed-citation></ref><ref id="R52"><mixed-citation publication-type="journal"><name><surname>Koelmel</surname><given-names>JP</given-names></name>, <name><surname>Kroeger</surname><given-names>NM</given-names></name>, <name><surname>Ulmer</surname><given-names>CZ</given-names></name>, <name><surname>Bowden</surname><given-names>JA</given-names></name>, <name><surname>Patterson</surname><given-names>RE</given-names></name>, <name><surname>Cochran</surname><given-names>JA</given-names></name>, &#x02026; <name><surname>Yost</surname><given-names>RA</given-names></name> (<year>2017</year>) <article-title>LipidMatch: An automated workflow for rule-based lipid identification using untargeted high-resolution tandem mass spectrometry data</article-title>. <source>BMC Bioinformatics</source>, <volume>18</volume>:<fpage>331</fpage>.<pub-id pub-id-type="pmid">28693421</pub-id></mixed-citation></ref><ref id="R53"><mixed-citation publication-type="journal"><name><surname>Kwan</surname><given-names>BC</given-names></name>, <name><surname>Kronenberg</surname><given-names>F</given-names></name>, <name><surname>Beddhu</surname><given-names>S</given-names></name>, &#x00026; <name><surname>Cheung</surname><given-names>AK</given-names></name> (<year>2007</year>) <article-title>Lipoprotein metabolism and lipid management in chronic kidney disease</article-title>. <source>Journal of the American Society of Nephrology</source>, <volume>18</volume>:<fpage>1246</fpage>&#x02013;<lpage>1261</lpage>.<pub-id pub-id-type="pmid">17360943</pub-id></mixed-citation></ref><ref id="R54"><mixed-citation publication-type="journal"><name><surname>Lev</surname><given-names>HM</given-names></name>, <name><surname>Ovental</surname><given-names>A</given-names></name>, <name><surname>Mandel</surname><given-names>D</given-names></name>, <name><surname>Mimouni</surname><given-names>FB</given-names></name>, <name><surname>Marom</surname><given-names>R</given-names></name>, &#x00026; <name><surname>Lubetzky</surname><given-names>R</given-names></name> (<year>2014</year>) <article-title>Major losses of fat, carbohydrates and energy content of preterm human milk frozen at &#x02014;80&#x000b0;C</article-title>. <source>Journal of Perinatology</source>, <volume>34</volume>:<fpage>396</fpage>&#x02013;<lpage>398</lpage>.<pub-id pub-id-type="pmid">24503916</pub-id></mixed-citation></ref><ref id="R55"><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>K</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, &#x00026; <name><surname>Chen</surname><given-names>F</given-names></name> (<year>2019</year>) <article-title>Effect of storage temperature on lipid oxidation and changes in nutrient contents in peanuts</article-title>. <source>Food Science &#x00026; Nutrition</source>, <volume>7</volume>:<fpage>2280</fpage>&#x02013;<lpage>2290</lpage>.<pub-id pub-id-type="pmid">31367356</pub-id></mixed-citation></ref><ref id="R56"><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>X</given-names></name>, <name><surname>Hoene</surname><given-names>M</given-names></name>, <name><surname>Yin</surname><given-names>P</given-names></name>, <name><surname>Fritsche</surname><given-names>L</given-names></name>, <name><surname>Plomgaard</surname><given-names>P</given-names></name>, <name><surname>Hansen</surname><given-names>JS</given-names></name>, &#x02026; <name><surname>Lehmann</surname><given-names>R</given-names></name> (<year>2018</year>) <article-title>Quality control of serum and plasma by quantification of (4E,14Z)-sphingadienine-C18-1-phosphate uncovers common Preanalytical errors during handling of whole</article-title>. <source>Blood</source>, <volume>64</volume>:<fpage>810</fpage>&#x02013;<lpage>819</lpage>.</mixed-citation></ref><ref id="R57"><mixed-citation publication-type="journal"><name><surname>Lonning</surname><given-names>PE</given-names></name>, <name><surname>Geisler</surname><given-names>J</given-names></name>, <name><surname>Krag</surname><given-names>LE</given-names></name>, <name><surname>Erikstein</surname><given-names>B</given-names></name>, <name><surname>Bremnes</surname><given-names>Y</given-names></name>, <name><surname>Hagen</surname><given-names>AI</given-names></name>, &#x02026; <name><surname>Massimini</surname><given-names>G</given-names></name> (<year>2005</year>) <article-title>Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer</article-title>. <source>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</source>, <volume>23</volume>:<fpage>5126</fpage>&#x02013;<lpage>5137</lpage>.<pub-id pub-id-type="pmid">15983390</pub-id></mixed-citation></ref><ref id="R58"><mixed-citation publication-type="journal"><name><surname>Lorenz</surname><given-names>MA</given-names></name>, <name><surname>Burant</surname><given-names>CF</given-names></name>, &#x00026; <name><surname>Kennedy</surname><given-names>RT</given-names></name> (<year>2011</year>) <article-title>Reducing time and increasing sensitivity in sample preparation for adherent mammalian cell metabolomics</article-title>. <source>Analytical Chemistry</source>, <volume>83</volume>:<fpage>3406</fpage>&#x02013;<lpage>3414</lpage>.<pub-id pub-id-type="pmid">21456517</pub-id></mixed-citation></ref><ref id="R59"><mixed-citation publication-type="journal"><name><surname>L&#x000fc;</surname><given-names>J-M</given-names></name>, <name><surname>Lin</surname><given-names>PH</given-names></name>, <name><surname>Yao</surname><given-names>Q</given-names></name>, &#x00026; <name><surname>Chen</surname><given-names>C</given-names></name> (<year>2010</year>) <article-title>Chemical and molecular mechanisms of antioxidants: Experimental approaches and model systems</article-title>. <source>Journal of Cellular and Molecular Medicine</source>, <volume>14</volume>:<fpage>840</fpage>&#x02013;<lpage>860</lpage>.<pub-id pub-id-type="pmid">19754673</pub-id></mixed-citation></ref><ref id="R60"><mixed-citation publication-type="journal"><name><surname>Lu</surname><given-names>W</given-names></name>, <name><surname>Su</surname><given-names>X</given-names></name>, <name><surname>Klein</surname><given-names>MS</given-names></name>, <name><surname>Lewis</surname><given-names>IA</given-names></name>, <name><surname>Fiehn</surname><given-names>O</given-names></name>, &#x00026; <name><surname>Rabinowitz</surname><given-names>JD</given-names></name> (<year>2017</year>) <article-title>Metabolite measurement: Pitfalls to avoid and practices to follow</article-title>. <source>Annual Review of Biochemistry</source>, <volume>86</volume>:<fpage>277</fpage>&#x02013;<lpage>304</lpage>.</mixed-citation></ref><ref id="R61"><mixed-citation publication-type="journal"><name><surname>Maddipati</surname><given-names>KR</given-names></name>, &#x00026; <name><surname>Zhou</surname><given-names>SL</given-names></name> (<year>2011</year>) <article-title>Stability and analysis of eicosanoids and docosanoids in tissue culture media</article-title>. <source>Prostaglandins &#x00026; Other Lipid Mediators</source>, <volume>94</volume>:<fpage>59</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="pmid">21236355</pub-id></mixed-citation></ref><ref id="R62"><mixed-citation publication-type="journal"><name><surname>Maskrey</surname><given-names>BH</given-names></name>, &#x00026; <name><surname>O&#x02019;Donnell</surname><given-names>VB</given-names></name> (<year>2008</year>) <article-title>Analysis of eicosanoids and related lipid mediators using mass spectrometry</article-title>. <source>Biochemical Society Transactions</source>, <volume>36</volume>:<fpage>1055</fpage>&#x02013;<lpage>1059</lpage>.<pub-id pub-id-type="pmid">18793188</pub-id></mixed-citation></ref><ref id="R63"><mixed-citation publication-type="journal"><name><surname>Massaro</surname><given-names>M</given-names></name>, <name><surname>Scoditti</surname><given-names>E</given-names></name>, <name><surname>Carluccio</surname><given-names>MA</given-names></name>, &#x00026; <name><surname>De Caterina</surname><given-names>R</given-names></name> (<year>2008</year>) <article-title>Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease</article-title>. <source>Prostaglandins, Leukotrienes, and Essential Fatty Acids</source>, <volume>79</volume>:<fpage>109</fpage>&#x02013;<lpage>115</lpage>.</mixed-citation></ref><ref id="R64"><mixed-citation publication-type="journal"><name><surname>Metherel</surname><given-names>AH</given-names></name>, <name><surname>Aristizabal Henao</surname><given-names>JJ</given-names></name>, &#x00026; <name><surname>Stark</surname><given-names>KD</given-names></name> (<year>2013</year>) <article-title>EPA and DHA levels in whole blood decrease more rapidly when stored at &#x02212;20&#x000b0;C as compared with room temperature, 4 and &#x02212;75&#x000b0;C</article-title>. <source>Lipids</source>, <volume>48</volume>:<fpage>1079</fpage>&#x02013;<lpage>1091</lpage>.<pub-id pub-id-type="pmid">23949919</pub-id></mixed-citation></ref><ref id="R65"><mixed-citation publication-type="journal"><name><surname>Metherel</surname><given-names>AH</given-names></name>, &#x00026; <name><surname>Stark</surname><given-names>KD</given-names></name> (<year>2015</year>) <article-title>Cryopreservation prevents iron-initiated highly unsaturated fatty acid loss during storage of human blood on chromatography paper at &#x02212;20<sup>&#x000b0;</sup>C</article-title>. <source>The Journal of Nutrition</source>, <volume>145</volume>:<fpage>654</fpage>&#x02013;<lpage>660</lpage>.<pub-id pub-id-type="pmid">25733485</pub-id></mixed-citation></ref><ref id="R66"><mixed-citation publication-type="journal"><name><surname>Metherel</surname><given-names>AH</given-names></name>, &#x00026; <name><surname>Stark</surname><given-names>KD</given-names></name> (<year>2016</year>) <article-title>The stability of blood fatty acids during storage and potential mechanisms of degradation: A review</article-title>. <source>Prostaglandins, Leukotrienes, and Essential Fatty Acids</source>, <volume>104</volume>:<fpage>33</fpage>&#x02013;<lpage>43</lpage>.</mixed-citation></ref><ref id="R67"><mixed-citation publication-type="journal"><name><surname>Min</surname><given-names>B</given-names></name>, &#x00026; <name><surname>Ahn</surname><given-names>DU</given-names></name> (<year>2005</year>) <article-title>Mechanism of lipid peroxidation in meat and meat products&#x02014;A review</article-title>. <source>Food Science and Biotechnology</source>, <volume>14</volume>:<fpage>152</fpage>&#x02013;<lpage>163</lpage>.</mixed-citation></ref><ref id="R68"><mixed-citation publication-type="journal"><name><surname>Mohamed</surname><given-names>AS</given-names></name>, <name><surname>Hosney</surname><given-names>M</given-names></name>, <name><surname>Bassiony</surname><given-names>H</given-names></name>, <name><surname>Hassanein</surname><given-names>SS</given-names></name>, <name><surname>Soliman</surname><given-names>AM</given-names></name>, <name><surname>Fahmy</surname><given-names>SR</given-names></name>, &#x00026; <name><surname>Gaafar</surname><given-names>K</given-names></name> (<year>2020</year>) <article-title>Sodium pento-barbital dosages for exsanguination affect biochemical, molecular and histological measurements in rats</article-title>. <source>Scientific Reports</source>, <volume>10</volume>:<fpage>378</fpage>.<pub-id pub-id-type="pmid">31942001</pub-id></mixed-citation></ref><ref id="R69"><mixed-citation publication-type="journal"><name><surname>Myers</surname><given-names>GL</given-names></name>, <name><surname>Kimberly</surname><given-names>MM</given-names></name>, <name><surname>Waymack</surname><given-names>PP</given-names></name>, <name><surname>Smith</surname><given-names>SJ</given-names></name>, <name><surname>Cooper</surname><given-names>GR</given-names></name>, &#x00026; <name><surname>Sampson</surname><given-names>EJ</given-names></name> (<year>2000</year>) <article-title>A reference method laboratory network for cholesterol: A model for standardization and improvement of clinical laboratory measurements</article-title>. <source>Clinical Chemistry</source>, <volume>46</volume>:<fpage>1762</fpage>&#x02013;<lpage>1772</lpage>.<pub-id pub-id-type="pmid">11067811</pub-id></mixed-citation></ref><ref id="R70"><mixed-citation publication-type="journal"><name><surname>Nawar</surname><given-names>WW</given-names></name> (<year>1969</year>) <article-title>Thermal degradation of lipids</article-title>. <source>Journal of Agricultural and Food Chemistry</source>, <volume>17</volume>:<fpage>18</fpage>&#x02013;<lpage>21</lpage>.</mixed-citation></ref><ref id="R71"><mixed-citation publication-type="journal"><name><surname>Nawar</surname><given-names>WW</given-names></name> (<year>1984</year>) <article-title>Chemical changes in lipids produced by thermal processing</article-title>. <source>Journal of Chemical Education</source>, <volume>61</volume>:<fpage>299</fpage>.</mixed-citation></ref><ref id="R72"><mixed-citation publication-type="journal"><name><surname>Ng</surname><given-names>W-Y</given-names></name>, &#x00026; <name><surname>Yeo</surname><given-names>C-P</given-names></name> (<year>2013</year>) <article-title>Thrombin-accelerated quick clotting serum tubes: An evaluation with 22 common biochemical analytes</article-title>. <source>Advances in Hematology</source>, <volume>2013</volume>:<fpage>769479</fpage>.<pub-id pub-id-type="pmid">23653649</pub-id></mixed-citation></ref><ref id="R73"><mixed-citation publication-type="journal"><name><surname>Ni</surname><given-names>Z</given-names></name>, <name><surname>Angelidou</surname><given-names>G</given-names></name>, <name><surname>Hoffmann</surname><given-names>R</given-names></name>, &#x00026; <name><surname>Fedorova</surname><given-names>M</given-names></name> (<year>2017</year>) <article-title>LPPtiger software for lipidome-specific prediction and identification of oxidized phospholipids from LC-MS datasets</article-title>. <source>Scientific Reports</source>, <volume>7</volume>:<fpage>15138</fpage>.<pub-id pub-id-type="pmid">29123162</pub-id></mixed-citation></ref><ref id="R74"><mixed-citation publication-type="journal"><name><surname>Nimse</surname><given-names>SB</given-names></name>, &#x00026; <name><surname>Pal</surname><given-names>D</given-names></name> (<year>2015</year>) <article-title>Free radicals, natural antioxidants, and their reaction mechanisms</article-title>. <source>RSC Advances</source>, <volume>5</volume>:<fpage>27986</fpage>&#x02013;<lpage>28006</lpage>.</mixed-citation></ref><ref id="R75"><mixed-citation publication-type="journal"><name><surname>Oberg</surname><given-names>BP</given-names></name>, <name><surname>McMenamin</surname><given-names>E</given-names></name>, <name><surname>Lucas</surname><given-names>FL</given-names></name>, <name><surname>McMonagle</surname><given-names>E</given-names></name>, <name><surname>Morrow</surname><given-names>J</given-names></name>, <name><surname>Ikizler</surname><given-names>TA</given-names></name>, &#x00026; <name><surname>Himmelfarb</surname><given-names>J</given-names></name> (<year>2004</year>) <article-title>Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease</article-title>. <source>Kidney International</source>, <volume>65</volume>:<fpage>1009</fpage>&#x02013;<lpage>1016</lpage>.<pub-id pub-id-type="pmid">14871421</pub-id></mixed-citation></ref><ref id="R76"><mixed-citation publication-type="journal"><name><surname>O&#x02019;Donnell</surname><given-names>VB</given-names></name>, <name><surname>Ekroos</surname><given-names>K</given-names></name>, <name><surname>Liebisch</surname><given-names>G</given-names></name>, &#x00026; <name><surname>Wakelam</surname><given-names>M</given-names></name> (<year>2019</year>) <article-title>Lipidomics: Current state of the art in a fast moving field</article-title>. <source>Wiley Interdisciplinary Reviews: Systems Biology and Medicine</source>, <volume>12</volume>:<fpage>e1466</fpage>.<pub-id pub-id-type="pmid">31646749</pub-id></mixed-citation></ref><ref id="R77"><mixed-citation publication-type="journal"><name><surname>Overmyer</surname><given-names>KA</given-names></name>, <name><surname>Thonusin</surname><given-names>C</given-names></name>, <name><surname>Qi</surname><given-names>NR</given-names></name>, <name><surname>Burant</surname><given-names>CF</given-names></name>, &#x00026; <name><surname>Evans</surname><given-names>CR</given-names></name> (<year>2015</year>) <article-title>Impact of anesthesia and euthanasia on metabolomics of mammalian tissues: Studies in a C57BL/6J mouse model</article-title>. <source>PLoS One</source>, <volume>10</volume>:<fpage>e0117232</fpage>.<pub-id pub-id-type="pmid">25658945</pub-id></mixed-citation></ref><ref id="R78"><mixed-citation publication-type="journal"><name><surname>Qiu</surname><given-names>Y</given-names></name>, <name><surname>Moir</surname><given-names>R</given-names></name>, <name><surname>Willis</surname><given-names>I</given-names></name>, <name><surname>Beecher</surname><given-names>C</given-names></name>, <name><surname>Tsai</surname><given-names>YH</given-names></name>, <name><surname>Garrett</surname><given-names>TJ</given-names></name>, &#x02026; <name><surname>Kurland</surname><given-names>IJ</given-names></name> (<year>2016</year>) <article-title>Isotopic ratio outlier analysis of the <italic>S. cerevisiae</italic> metabolome using accurate mass gas chromatography/time-of-flight mass spectrometry: A new method for discovery</article-title>. <source>Analytical Chemistry</source>, <volume>88</volume>:<fpage>2747</fpage>&#x02013;<lpage>2754</lpage>.<pub-id pub-id-type="pmid">26820234</pub-id></mixed-citation></ref><ref id="R79"><mixed-citation publication-type="journal"><name><surname>Rampler</surname><given-names>E</given-names></name>, <name><surname>Criscuolo</surname><given-names>A</given-names></name>, <name><surname>Zeller</surname><given-names>M</given-names></name>, <name><surname>El Abiead</surname><given-names>Y</given-names></name>, <name><surname>Schoeny</surname><given-names>H</given-names></name>, <name><surname>Hermann</surname><given-names>G</given-names></name>, &#x02026; <name><surname>Koellensperger</surname><given-names>G</given-names></name> (<year>2018</year>) <article-title>A novel Lipidomics workflow for improved human plasma identification and quantification using RPLC-MSn methods and isotope dilution strategies</article-title>. <source>Analytical Chemistry</source>, <volume>90</volume>:<fpage>6494</fpage>&#x02013;<lpage>6501</lpage>.<pub-id pub-id-type="pmid">29708737</pub-id></mixed-citation></ref><ref id="R80"><mixed-citation publication-type="journal"><name><surname>Ridker</surname><given-names>PM</given-names></name>, <name><surname>Rifai</surname><given-names>N</given-names></name>, <name><surname>Cook</surname><given-names>NR</given-names></name>, <name><surname>Bradwin</surname><given-names>G</given-names></name>, &#x00026; <name><surname>Buring</surname><given-names>JE</given-names></name> (<year>2005</year>) <article-title>Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women</article-title>. <source>JAMA</source>, <volume>294</volume>:<fpage>326</fpage>&#x02013;<lpage>333</lpage>.<pub-id pub-id-type="pmid">16030277</pub-id></mixed-citation></ref><ref id="R81"><mixed-citation publication-type="journal"><name><surname>Rose</surname><given-names>DJ</given-names></name>, <name><surname>Ogden</surname><given-names>LV</given-names></name>, <name><surname>Dunn</surname><given-names>ML</given-names></name>, &#x00026; <name><surname>Pike</surname><given-names>OA</given-names></name> (<year>2008</year>) <article-title>Enhanced lipid stability in whole wheat flour by lipase inactivation and antioxidant retention</article-title>. <source>Cereal Chemistry Journal</source>, <volume>85</volume>:<fpage>218</fpage>&#x02013;<lpage>223</lpage>.</mixed-citation></ref><ref id="R82"><mixed-citation publication-type="journal"><name><surname>Roszkowska</surname><given-names>A</given-names></name>, <name><surname>Yu</surname><given-names>M</given-names></name>, <name><surname>Bessonneau</surname><given-names>V</given-names></name>, <name><surname>Bragg</surname><given-names>L</given-names></name>, <name><surname>Servos</surname><given-names>M</given-names></name>, &#x00026; <name><surname>Pawliszyn</surname><given-names>J</given-names></name> (<year>2018</year>) <article-title>Tissue storage affects lipidome profiling in comparison to in vivo microsampling approach</article-title>. <source>Scientific Reports</source>, <volume>8</volume>:<fpage>6980</fpage>.<pub-id pub-id-type="pmid">29725071</pub-id></mixed-citation></ref><ref id="R83"><mixed-citation publication-type="journal"><name><surname>Roughan</surname><given-names>PG</given-names></name>, <name><surname>Slack</surname><given-names>CR</given-names></name>, &#x00026; <name><surname>RJL</surname><given-names>H</given-names></name> (<year>1978</year>) <article-title>Generation of phospholipid artefacts during extraction of developing soybean seeds with methanolic solvents</article-title>. <source>Lipids</source>, <volume>13</volume>:<fpage>497</fpage>&#x02013;<lpage>503</lpage>.</mixed-citation></ref><ref id="R84"><mixed-citation publication-type="book"><name><surname>Schantz</surname><given-names>MM</given-names></name>, <name><surname>Powers</surname><given-names>CD</given-names></name>, &#x00026; <name><surname>Schleicher</surname><given-names>RL</given-names></name> (<year>2013</year>) <source>Interlaboratory analytical comparison study of total fatty acid concentrations in human serum: results for Exercise 01: QA12FASER01</source>. <comment>NISTIR7953</comment>, pp. <fpage>1</fpage>&#x02013;<lpage>82</lpage>.</mixed-citation></ref><ref id="R85"><mixed-citation publication-type="journal"><name><surname>Shahidi</surname><given-names>F</given-names></name>, &#x00026; <name><surname>Zhong</surname><given-names>Y</given-names></name> (<year>2010</year>) <article-title>Lipid oxidation and improving the oxidative stability</article-title>. <source>Chemical Society Reviews</source>, <volume>39</volume>:<fpage>4067</fpage>&#x02013;<lpage>4079</lpage>.<pub-id pub-id-type="pmid">20617249</pub-id></mixed-citation></ref><ref id="R86"><mixed-citation publication-type="journal"><name><surname>Shen</surname><given-names>Z</given-names></name>, &#x00026; <name><surname>Wijesundera</surname><given-names>C</given-names></name> (<year>2009</year>) <article-title>Effects of docosahexaenoic acid positional distribution on the oxidative stability of model triacylglycerol in water emulsion</article-title>. <source>Journal of Food Lipids</source>, <volume>16</volume>:<fpage>62</fpage>&#x02013;<lpage>71</lpage>.</mixed-citation></ref><ref id="R87"><mixed-citation publication-type="journal"><name><surname>Sohaib</surname><given-names>M</given-names></name>, <name><surname>Butt</surname><given-names>MS</given-names></name>, <name><surname>Shabbir</surname><given-names>MA</given-names></name>, &#x00026; <name><surname>Shahid</surname><given-names>M</given-names></name> (<year>2015</year>) <article-title>Lipid stability, antioxidant potential and fatty acid composition of broilers breast meat as influenced by quercetin in combination with alpha-tocopherol enriched diets</article-title>. <source>Lipids in Health and Disease</source>, <volume>14</volume>:<fpage>61</fpage>.<pub-id pub-id-type="pmid">26104386</pub-id></mixed-citation></ref><ref id="R88"><mixed-citation publication-type="journal"><name><surname>Stegemann</surname><given-names>C</given-names></name>, <name><surname>Pechlaner</surname><given-names>R</given-names></name>, <name><surname>Willeit</surname><given-names>P</given-names></name>, <name><surname>Langley</surname><given-names>SR</given-names></name>, <name><surname>Mangino</surname><given-names>M</given-names></name>, <name><surname>Mayr</surname><given-names>U</given-names></name>, &#x02026; <name><surname>Mayr</surname><given-names>M</given-names></name> (<year>2014</year>) <article-title>Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study</article-title>. <source>Circulation</source>, <volume>129</volume>:<fpage>1821</fpage>&#x02013;<lpage>1831</lpage>.<pub-id pub-id-type="pmid">24622385</pub-id></mixed-citation></ref><ref id="R89"><mixed-citation publication-type="journal"><name><surname>Stevens</surname><given-names>VL</given-names></name>, <name><surname>Hoover</surname><given-names>E</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, &#x00026; <name><surname>Zanetti</surname><given-names>KA</given-names></name> (<year>2019</year>) <article-title>Pre-analytical factors that affect metabolite stability in human urine, plasma, and serum: A review</article-title>. <source>Metabolites</source>, <volume>9</volume>:<fpage>156</fpage>.</mixed-citation></ref><ref id="R90"><mixed-citation publication-type="journal"><name><surname>Stupp</surname><given-names>GS</given-names></name>, <name><surname>Clendinen</surname><given-names>CS</given-names></name>, <name><surname>Ajredini</surname><given-names>R</given-names></name>, <name><surname>Szewc</surname><given-names>MA</given-names></name>, <name><surname>Garrett</surname><given-names>T</given-names></name>, <name><surname>Menger</surname><given-names>RF</given-names></name>, &#x02026; <name><surname>Edison</surname><given-names>AS</given-names></name> (<year>2013</year>) <article-title>Isotopic ratio outlier analysis global metabolomics of <italic>Caenorhabditis elegans</italic></article-title>. <source>Analytical Chemistry</source>, <volume>85</volume>:<fpage>11858</fpage>&#x02013;<lpage>11865</lpage>.<pub-id pub-id-type="pmid">24274725</pub-id></mixed-citation></ref><ref id="R91"><mixed-citation publication-type="journal"><name><surname>Sutphen</surname><given-names>R</given-names></name>, <name><surname>Xu</surname><given-names>Y</given-names></name>, <name><surname>Wilbanks</surname><given-names>GD</given-names></name>, <name><surname>Fiorica</surname><given-names>J</given-names></name>, <name><surname>Grendys</surname><given-names>EC</given-names></name>, <name><surname>LaPolla</surname><given-names>JP</given-names></name>, . <name><surname>Krischer</surname><given-names>JP</given-names></name> (<year>2004</year>) <article-title>Lysophospholipids are potential biomarkers of ovarian cancer</article-title>. <source>Cancer Epidemiology Biomarkers &#x00026; Prevention</source>, <volume>13</volume>:<fpage>1185</fpage>&#x02013;<lpage>1191</lpage>.</mixed-citation></ref><ref id="R92"><mixed-citation publication-type="journal"><name><surname>Thompson</surname><given-names>JW</given-names></name>, <name><surname>Adams</surname><given-names>KJ</given-names></name>, <name><surname>Adamski</surname><given-names>J</given-names></name>, <name><surname>Asad</surname><given-names>Y</given-names></name>, <name><surname>Boris</surname><given-names>D</given-names></name>, <name><surname>Bowden</surname><given-names>JA</given-names></name>, &#x02026; <name><surname>Moseley</surname><given-names>MA</given-names></name> (<year>2019</year>) <article-title>International ring trial of a high resolution targeted metabolomics and Lipidomics platform for serum and plasma analysis</article-title>. <source>Analytical Chemistry</source>, <volume>91</volume>:<fpage>14407</fpage>&#x02013;<lpage>14416</lpage>.<pub-id pub-id-type="pmid">31638379</pub-id></mixed-citation></ref><ref id="R93"><mixed-citation publication-type="journal"><name><surname>Tr&#x000e9;panier</surname><given-names>M-O</given-names></name>, <name><surname>Eiden</surname><given-names>M</given-names></name>, <name><surname>Morin-Rivron</surname><given-names>D</given-names></name>, <name><surname>Bazinet</surname><given-names>RP</given-names></name>, &#x00026; <name><surname>Masoodi</surname><given-names>M</given-names></name> (<year>2017</year>) <article-title>High-resolution lipidomics coupled with rapid fixation reveals novel ischemia-induced signaling in the rat neurolipidome</article-title>. <source>Journal of Neurochemistry</source>, <volume>140</volume>:<fpage>766</fpage>&#x02013;<lpage>775</lpage>.<pub-id pub-id-type="pmid">28002627</pub-id></mixed-citation></ref><ref id="R94"><mixed-citation publication-type="journal"><name><surname>Tsugawa</surname><given-names>H</given-names></name>, <name><surname>Cajka</surname><given-names>T</given-names></name>, <name><surname>Kind</surname><given-names>T</given-names></name>, <name><surname>Ma</surname><given-names>Y</given-names></name>, <name><surname>Higgins</surname><given-names>B</given-names></name>, <name><surname>Ikeda</surname><given-names>K</given-names></name>, &#x02026; <name><surname>Arita</surname><given-names>M</given-names></name> (<year>2015</year>) <article-title>MS-DIAL: Data-independent MS/MS deconvolution for comprehensive metabolome analysis</article-title>. <source>Nature Methods</source>, <volume>12</volume>:<fpage>523</fpage>&#x02013;<lpage>526</lpage>.<pub-id pub-id-type="pmid">25938372</pub-id></mixed-citation></ref><ref id="R95"><mixed-citation publication-type="journal"><name><surname>Ulmer</surname><given-names>CZ</given-names></name>, <name><surname>Ragland</surname><given-names>JM</given-names></name>, <name><surname>Koelmel</surname><given-names>JP</given-names></name>, <name><surname>Heckert</surname><given-names>A</given-names></name>, <name><surname>Jones</surname><given-names>CM</given-names></name>, <name><surname>Garrett</surname><given-names>TJ</given-names></name>, &#x02026; <name><surname>Bowden</surname><given-names>JA</given-names></name> (<year>2017</year>) <article-title>LipidQC: Method validation tool for visual comparison to SRM 1950 using NIST Interlaboratory comparison exercise lipid consensus mean estimate values</article-title>. <source>Analytical Chemistry</source>, <volume>89</volume>:<fpage>13069</fpage>&#x02013;<lpage>13073</lpage>.<pub-id pub-id-type="pmid">29148710</pub-id></mixed-citation></ref><ref id="R96"><mixed-citation publication-type="journal"><name><surname>Velasco</surname><given-names>J</given-names></name>, &#x00026; <name><surname>Dobarganes</surname><given-names>C</given-names></name> (<year>2002</year>) <article-title>Oxidative stability of virgin olive oil</article-title>. <source>European Journal of Lipid Science and Technology</source>, <volume>104</volume>:<fpage>661</fpage>&#x02013;<lpage>676</lpage>.</mixed-citation></ref><ref id="R97"><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Gu</surname><given-names>X</given-names></name>, <name><surname>Song</surname><given-names>H</given-names></name>, <name><surname>Song</surname><given-names>Q</given-names></name>, <name><surname>Gao</surname><given-names>X</given-names></name>, <name><surname>Lu</surname><given-names>Y</given-names></name>, &#x00026; <name><surname>Chen</surname><given-names>H</given-names></name> (<year>2015</year>) <article-title>Phenylmethanesulfonyl fluoride pretreatment stabilizes plasma lipidome in lipidomic and metabolomic analysis</article-title>. <source>Analytica Chimica Acta</source>, <volume>893</volume>:<fpage>77</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="pmid">26398425</pub-id></mixed-citation></ref><ref id="R98"><mixed-citation publication-type="journal"><name><surname>Warnick</surname><given-names>GR</given-names></name>, <name><surname>Kimberly</surname><given-names>MM</given-names></name>, <name><surname>Waymack</surname><given-names>PP</given-names></name>, <name><surname>Leary</surname><given-names>ET</given-names></name>, &#x00026; <name><surname>Myers</surname><given-names>GL</given-names></name> (<year>2008</year>) <article-title>Standardization of measurements for cholesterol, triglycerides, and major lipoproteins</article-title>. <source>Laboratory Medicine</source>, <volume>39</volume>:<fpage>481</fpage>&#x02013;<lpage>490</lpage>.</mixed-citation></ref><ref id="R99"><mixed-citation publication-type="journal"><name><surname>Watson</surname><given-names>AD</given-names></name> (<year>2006</year>) <article-title>Thematic review series: Systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems</article-title>. <source>Journal of Lipid Research</source>, <volume>47</volume>:<fpage>2101</fpage>&#x02013;<lpage>2111</lpage>.<pub-id pub-id-type="pmid">16902246</pub-id></mixed-citation></ref><ref id="R100"><mixed-citation publication-type="journal"><name><surname>Xu</surname><given-names>Y</given-names></name>, <name><surname>Zhao</surname><given-names>Z</given-names></name>, <name><surname>Xiao</surname><given-names>Y</given-names></name>, <name><surname>Elson</surname><given-names>P</given-names></name>, <name><surname>Tan</surname><given-names>H</given-names></name>, <name><surname>Plummer</surname><given-names>S</given-names></name>, &#x02026; <name><surname>Graham</surname><given-names>C</given-names></name> (<year>2007</year>) <article-title>Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer</article-title>. <source>Journal of Clnical Oncology</source>, <volume>67</volume>:<fpage>1687</fpage>&#x02013;<lpage>1687</lpage>.</mixed-citation></ref><ref id="R101"><mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>W</given-names></name>, <name><surname>Chen</surname><given-names>Y</given-names></name>, <name><surname>Xi</surname><given-names>C</given-names></name>, <name><surname>Zhang</surname><given-names>R</given-names></name>, <name><surname>Song</surname><given-names>Y</given-names></name>, <name><surname>Zhan</surname><given-names>Q</given-names></name>, &#x02026; <name><surname>Abliz</surname><given-names>Z</given-names></name> (<year>2013</year>) <article-title>Liquid chromatography-tandem mass spectrometry-based plasma metabonomics delineate the effect of metabolites&#x02019; stability on reliability of potential biomarkers</article-title>. <source>Analytical Chemistry</source>, <volume>85</volume>:<fpage>2606</fpage>&#x02013;<lpage>2610</lpage>.<pub-id pub-id-type="pmid">23387999</pub-id></mixed-citation></ref><ref id="R102"><mixed-citation publication-type="journal"><name><surname>Yun</surname><given-names>J-M</given-names></name>, &#x00026; <name><surname>Surh</surname><given-names>J</given-names></name> (<year>2012</year>) <article-title>Fatty acid composition as a predictor for the oxidation stability of Korean vegetable oils with or without induced oxidative stress</article-title>. <source>Preventive Nutrition and Food Science</source>, <volume>17</volume>:<fpage>158</fpage>&#x02013;<lpage>165</lpage>.<pub-id pub-id-type="pmid">24471078</pub-id></mixed-citation></ref><ref id="R103"><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>WL</given-names></name>, <name><surname>Liu</surname><given-names>MY</given-names></name>, <name><surname>Zhang</surname><given-names>ZC</given-names></name>, &#x00026; <name><surname>Duan</surname><given-names>CY</given-names></name> (<year>2013</year>) <article-title>Effect of different anesthesia methods on erythrocyte immune function in mice</article-title>. <source>Asian Pacific Journal of Tropical Medicine</source>, <volume>6</volume>:<fpage>995</fpage>&#x02013;<lpage>998</lpage>.<pub-id pub-id-type="pmid">24144035</pub-id></mixed-citation></ref><ref id="R104"><mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>X</given-names></name>, <name><surname>Mao</surname><given-names>J</given-names></name>, <name><surname>Ai</surname><given-names>J</given-names></name>, <name><surname>Deng</surname><given-names>Y</given-names></name>, <name><surname>Roth</surname><given-names>MR</given-names></name>, <name><surname>Pound</surname><given-names>C</given-names></name>, &#x02026; <name><surname>Bigler</surname><given-names>SA</given-names></name> (<year>2012</year>) <article-title>Identification of plasma lipid biomarkers for prostate cancer by lipidomics and bioinformatics</article-title>. <source>PLoS One</source>, <volume>7</volume>:<fpage>e48889</fpage>.<pub-id pub-id-type="pmid">23152813</pub-id></mixed-citation></ref><ref id="R105"><mixed-citation publication-type="journal"><name><surname>Zivkovic</surname><given-names>AM</given-names></name>, <name><surname>Wiest</surname><given-names>MM</given-names></name>, <name><surname>Nguyen</surname><given-names>UT</given-names></name>, <name><surname>Davis</surname><given-names>R</given-names></name>, <name><surname>Watkins</surname><given-names>SM</given-names></name>, &#x00026; <name><surname>German</surname><given-names>JB</given-names></name> (<year>2009</year>) <article-title>Effects of sample handling and storage on quantitative lipid analysis in human serum</article-title>. <source>Metabolomics</source>, <volume>5</volume>:<fpage>507</fpage>&#x02013;<lpage>516</lpage>.<pub-id pub-id-type="pmid">20046864</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Fig 1</label><caption><p id="P65">One possible mechanism of lipid peroxidation and chain propagation. Further reactions can occur, which create short-chain products (aldehydes and carboxylic acids) and other long-chain products (ketones and epoxies)</p></caption><graphic xlink:href="nihms-1608100-f0001"/></fig><fig id="F2" orientation="portrait" position="float"><label>Fig 2</label><caption><p id="P66">Major enzymatic degradation pathway that commonly occurs during sample processing for glycerophospholipids. The enzymes, phospholipase A1, A2, C, and D (PLA1, PLA2, PLC, and PLD, respectively) are responsible for cleaving phospholipids (PL) at ester linkages (PLA1 and PLA2), and different positions on the phosphate-containing headgroup (PLC and PLD). PLA1 and PLA2 cleave off fatty acyl chains resulting in both fatty acids (FA) and lysophospholipids (LPL). PLC and PLD generate diacylglycerols (DAG) from PL, with a phosphatidic acid intermediate in the case of PLD. DAG can also be generated <italic>via</italic> kinases and PLC from phosphatidyl inositol as well as by triacylglycerol lipases (TGL) for triacylglycerols (TAG). During extraction procedures in the presence of different alcohols (<italic>e.g.</italic>, methanol or ethanol), PLD can lead to the addition of carbons onto the phosphate group as well as the removal of the other attached functional groups, diacylglycerols (DAG), generating phosphatidylmethanol (PMe), phosphatidylethanol (PEt), or other nonendogenous species</p></caption><graphic xlink:href="nihms-1608100-f0002"/></fig><table-wrap id="T1" position="float" orientation="landscape"><label>Table 1</label><caption><p id="P67">Suggested recommendations for ensuring lipid stability</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Sample collection</td><td align="left" valign="top" rowspan="1" colspan="1">Pre-collection considerations</td><td align="left" valign="top" rowspan="1" colspan="1">While fresh samples allow for the best representation of an unaltered lipidome, frozen samples are acceptable as long as procedures are employed to ensure lipid stability.<break/>Plasma preparation from whole blood collected in tubes containing an anticoagulant is preferred, as anti-clotting agents such as EDTA can capture heavy metals, which are pro-oxidants.<break/>Because studies have shown the type of anticoagulant used to impact lipid extraction, create interferences, and/or result in the degradation of certain lipid classes, the same anticoagulant should be utilized for all samples within a study and among studies that will be compared.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sample handling</td><td align="left" valign="top" rowspan="1" colspan="1">Post-collection considerations</td><td align="left" valign="top" rowspan="1" colspan="1">After collection, all samples should be kept cold until sample preparation can be performed.<break/>Samples should ideally be immediately stored frozen until sample analysis at &#x02212;20 &#x000b0;C or lower.<break/>If samples cannot be stored frozen, the time between collection and sample analysis should be minimal.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sample preparation</td><td align="left" valign="top" rowspan="1" colspan="1">Internal standards</td><td align="left" valign="top" rowspan="1" colspan="1">If available, structurally similar internal standards should be spiked into samples before sample preparation to assess sample variability.<break/>The internal standards selected should be absent in the sample matrix and should closely represent the lipid class of interest.<break/>Lipid markers such as sphingadienine 1-phosphate, spingosine-1-phosphate, and lysophosphatidylcholine 18:2 have been proposed for use in assessing sample quality and pre-analytical variation. However, caution should be employed as these markers have not been assessed in larger cohort studies, as a panel of independent markers, or in other matrices apart from human serum and plasma.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Flash-freezeing</td><td align="left" valign="top" rowspan="1" colspan="1">If applicable, samples can be flash frozen in liquid nitrogen to quench enzymatic activity. Sample preparation should continue to be performed in a cold environment.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Additivies</td><td align="left" valign="top" rowspan="1" colspan="1">The use of additives such as phenylmethanesulfonyl fluroride (PMSF) have been shown to reduce the incidences of oxidization and enzymatic degradation of lipid species.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Antioxidants</td><td align="left" valign="top" rowspan="1" colspan="1">The use of antioxidants is encouraged during sample preparation to prevent the degradation of lipid species by (per)oxidation.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Heat-treatment</td><td align="left" valign="top" rowspan="1" colspan="1">For sample matrices where additives and antioxidant addition is challenging such as with tissue samples, heat treatment, which can be directly applied to the sample or solvent, has been shown to improve the stability of phospholipids, triacylglycerols, and sphingolipids during sample preparation through the inhibition of lipases.<break/>However, it should be noted that the non-enzymatic physical and chemical degradation of lipids are not accounted for with this technique.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Storage conditions</td><td align="left" valign="top" rowspan="1" colspan="1">Short-term</td><td align="left" valign="top" rowspan="1" colspan="1">The short-term storage of lipid extracts at room temperature and at 4 &#x000b0;C should be avoided as enzymatic activity has been shown to still be present.<break/>Lipids should be stored in an environment free of water, oxygen, and/or light to avoid the chemical transformation of certain lipid species.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Long-term</td><td align="left" valign="top" rowspan="1" colspan="1">If applicable, samples can be flash frozen in liquid nitrogen and stored at &#x02212;20&#x000b0;C or lower.<break/>Lipid extracts should be stored absent of oxygen (under nitrogen), light, metal ions, and peroxides in an organic solvent to avoid sublimation.<break/>Lipid extracts should be stored at &#x02212;20 &#x000b0;C or lower.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Freeze&#x02013;thaw cycles</td><td align="left" valign="top" rowspan="1" colspan="1">Laboratories should assess the effect of multiple freeze thaw cycles on the lipid class(es) of interest in a similar matrix as this is sample-dependent.<break/>If the lipid class of interest is affected by multiple freeze thaw cycles, biofluids should be aliquoted and tissues should be sliced appropriately to allow for multiple analyses.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Standardization efforts</td><td align="left" valign="top" rowspan="1" colspan="1">Targeted</td><td align="left" valign="top" rowspan="1" colspan="1">Depending on the analyte, laboratories can participate in the following QA/QC programs to ensure accuracy in lipid measurements:<break/>&#x02022; [CDC] Lipid Standardization Program (LSP) for total cholesterol, triacylglycerols, high-density lipoprotein cholesterol, apolipoprotein A-I, and apolipoprotein B<break/>&#x02022; [NIST and NIH ODS] Health Assessment Measurements Quality Assurance Program (HAMQAP) for free fatty acids</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Untargeted</td><td align="left" valign="top" rowspan="1" colspan="1">While no formal lipid measurement standardization/harmonization programs are currently in place for untargeted lipidomics studies, the following efforts exist:<break/>&#x02022; LipidQC is a method validation tool established by NIST for robust untargeted lipidomics platforms, which can be used to compare experimental results from NIST SRM 1950 to consensus mean concentrations derived from the 2017 NIST Lipidomics Interlaboratory Comparison Exercise.<break/>&#x02022; The results from various lipidomics international ring trials and interlaboratory studies have been reported in literature and can be used as a point of reference.</td></tr></tbody></table></table-wrap></floats-group></article>